<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20220728</date><key>pmc.key</key><document><id>9315516</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.3390/vetsci9070363</infon><infon key="article-id_pmc">9315516</infon><infon key="article-id_pmid">35878380</infon><infon key="article-id_publisher-id">vetsci-09-00363</infon><infon key="elocation-id">363</infon><infon key="issue">7</infon><infon key="kwd">COVID-19 anti-SARS-CoV-2 antibodies household human–animal interaction</infon><infon key="license">Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).</infon><infon key="name_0">surname:Oliveira;given-names:Andreia</infon><infon key="name_1">surname:Pereira;given-names:Maria Aires</infon><infon key="name_2">surname:Mateus;given-names:Teresa Letra</infon><infon key="name_3">surname:Mesquita;given-names:João R.</infon><infon key="name_4">surname:Vala;given-names:Helena</infon><infon key="name_5">surname:Kato;given-names:Atsushi</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">9</infon><infon key="year">2022</infon><offset>0</offset><text>Seroprevalence of SARS-CoV-2 in Client-Owned Cats from Portugal</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>64</offset><text>Simple Summary</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>79</offset><text>Domestic cats are highly susceptible to SARS-CoV-2. The close contact between humans and cats raises concerns about virus transmission from humans to cats. Thus, this study aims to investigate the presence of antibodies against SARS-CoV-2 in client-owned cats from Portugal, which is an indicator of exposure to the virus. A total of 176 cats, belonging to 94 households, were sampled, and cat owners answered an online questionnaire. Twenty households reported at least one confirmed human COVID-19 case. Forty cats belonged to COVID-19-positive and 136 to COVID-19-negative households. The percentages of cats exhibiting antibodies against SARS-CoV-2 from COVID-19-positive and -negative households were 5.0% and 0.7%, respectively. The two positive cats from COVID-19-positive households had an indoor lifestyle, and their owners maintained a close and frequent contact with them, even after being diagnosed with COVID-19, pointing towards human-to-cat transmission. The positive cat from the COVID-19-negative household had a mixed indoor/outdoor lifestyle and chronic diseases. Owners of the three positive cats did not notice clinical signs or behavior changes. This study highlights the low risk of SARS-CoV-2 transmission from humans to cats, even in a context of close and frequent contact.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1379</offset><text>Abstract</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1388</offset><text>The close contact between humans and domestic cats raises concerns about the potential risks of SARS-CoV-2 transmission. Thus, this study aims to investigate anti-SARS-CoV-2 seroprevalence in client-owned cats from Portugal and evaluate the infection risk of cats that maintain contact with human COVID-19 cases. A total of 176 cats, belonging to 94 households, were sampled. Cat owners answered an online questionnaire, and cats were screened for antibodies against SARS-CoV-2 using a commercial ELISA. Twenty (21.3%) households reported at least one confirmed human COVID-19 case. Forty cats (22.7%) belonged to a COVID-19-positive and 136 (77.3%) to a COVID-19-negative household. The seroprevalences of cats from COVID-19-positive and -negative households were 5.0% (2/40) and 0.7% (1/136). The two SARS-CoV-2-seropositive cats from COVID-19-positive households had an indoor lifestyle, and their owners stated that they maintained a close and frequent contact with them, even after being diagnosed with COVID-19, pointing towards human-to-cat transmission. The SARS-CoV-2-seropositive cat from the COVID-19-negative household had a mixed indoor/outdoor lifestyle and chronic diseases. Owners of the three SARS-CoV-2-seropositive cats did not notice clinical signs or behavior changes. This study highlights the low risk of SARS-CoV-2 transmission from COVID-19-positive human household members to domestic cats, even in a context of close and frequent human–animal contact. </text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>2870</offset><text>1. Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2886</offset><text>In December 2019, cases of pneumonia of unknown origin were reported in the city of Wuhan, located at the Chinese province of Hubei. A novel coronavirus (2019-nCoV) was identified as the causative agent of the disease by Chinese authorities, and the disease officially designated as Coronavirus Disease of 2019 (COVID-19) was classified as pandemic by the World Health Organization (WHO). Afterwards, due to the severe acute respiratory syndrome caused by the new coronavirus, the designation of the virus changed to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). </text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3466</offset><text>SARS-CoV-2 belongs to the genus Betacoronavirus and is a spherical, enveloped virus with surface projections that give rise to the corona appearance (spike proteins). SARS-CoV-2 contains a large positive-sense RNA genome, which is wrapped up in helical nucleocapsid.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3733</offset><text>The first reports of COVID-19 human outbreaks were documented in Wuhan, attributed to the consumption of wild animals, traded in markets named “wet markets”. The WHO does not confirm specifically this source; however, the diversity of susceptible species and the biological and virological characteristics of SARS-CoV and SARS-CoV-2-related viruses, mainly based on spike protein plasticity, strongly suggests a propensity for these viruses to cross the species barrier, particularly in the context of frequent contact. </text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4258</offset><text>In the face of this, the close association between humans and companion animals raised concerns about the potential risks of SARS-CoV-2 transmission from humans to animals (“reverse zoonosis”) and about the possible role infected animals could play in perpetuating the spread of COVID-19. The role of domestic cats (Felis catus) has aroused particular interest, because they are one of the most popular companion animals and often establish close and frequent contact with humans. Furthermore, cats are known to be infected by an Alphacoronavirus, the Feline coronavirus (FCoV), that is endemic in cat populations and responsible for a mild enteric disease. However, FCoV can evolve through a process of “internal mutation” into a severe and mostly lethal form, responsible for feline infectious peritonitis (FIP). </text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5082</offset><text>Furthermore, it was demonstrated that SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) as cellular receptor and that feline ACE2 protein is closely related to human ACE2, sharing a high amino acid sequence identity (85.2%). Indeed, feline and human ACE2 differ in only four out of the twenty residues of the ACE2 conforming receptor binding pocket, justifying the high susceptibility of felids to SARS-CoV-2 infection, already confirmed through several experimental studies. After experimental infection, cats may remain clinically asymptomatic but be capable of transmitting SARS-CoV-2 to other cats or may develop symptomatic infections, including severe disease and death. Histopathologic studies revealed massive lesions in the nasal and tracheal mucosa epitheliums and in the lungs.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5876</offset><text>Natural infection has been widely reported in cats after known or suspected close contact with human COVID-19 cases. Transmission from humans to cats is suggested by sequence analysis of viral genomes isolated from domestic cats and humans, which has revealed a high degree of sequence conservation. As in the case of experimental infection, some naturally infected cats remain asymptomatic, but others develop clinical disease, ranging from mild upper respiratory disease, including oral lesions and tongue ulceration, fever, sneezing, and ocular discharge, to moderate respiratory and/or gastrointestinal disease. </text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6493</offset><text>Serological investigations have revealed variable prevalence of infection in cats. In Wuhan, 14.7% of domestic cats, sampled from a local veterinary hospital during the outbreak, tested positive for anti-SARS-CoV-2 antibodies. However, samples taken from cats in 2020 in Germany and the United States revealed much lower seroprevalences, ranging from 0.7% to 8%. Higher seroprevalences were frequently reported in cats from households with human COVID-19 cases, highlighting the risk of human-to-animal SARS-CoV-2 transmission.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>7021</offset><text>This observational retrospective study aims to investigate anti-SARS-CoV-2 seroprevalence in client-owned cats from Portugal and determine the risk of natural infection of domestic cats that maintained sustained contact with human household members. </text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>7272</offset><text>2. Materials and Methods </text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>7298</offset><text>2.1. Animal Recruiting and Sampling</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7334</offset><text>Convenience sampling was used to select veterinary centers (clinics and hospitals) for this investigation, as we were living during a pandemic and facing long periods of confinement and conditional travel. Eighteen veterinary centers from mainland Portugal were invited by email to participate in this study. Veterinary centers (8/18) that agreed to collaborate received detailed instructions for sample collection and storage, informed consent form, and a link to receive access to an online questionnaire for owners. </text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7854</offset><text>During healthcare visits, veterinary practitioners from collaborating veterinary centers invited cat owners to participate in the study. Cat owners who agreed to collaborate answered an online questionnaire designed to collect background information. Blood samples were collected according to veterinary norms into dry tubes and then centrifugated at 500 rcf for 10 min. Supernatants were transferred to 2 mL microtubes and stored at −20 °C until sent to Escola Superior Agrária de Viseu (ESAV) laboratory. Sample collection took place between November 2020 and October 2021.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>8434</offset><text>2.2. Background Data Collection</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>8466</offset><text>A questionnaire was developed using an online platform (Google Forms®, Google LLC, Mountain View, California, United States) to collect data from each cat and household. The questionnaire was prepared in Portuguese language and consisted of 29 questions, of which 27 were closed-ended (dichotomic, multiple choice) and two were open-ended. The questionnaire covered five main topics, specifically: characterization of households, including human and animal elements and human–animal interaction (11 questions); characterization of sampled cats, including full signalment, lifestyle, prophylactic, and medical history (13 questions); and diagnoses of COVID-19 in cat owner and/or in other human members of the household (2 dichotomic questions, Yes/No). If respondents answered Yes to one of these two questions, they would answer questions on another topic designed to characterize COVID-19 diagnoses and interaction with the cat during the period of isolation (three questions) (Appendix A Table A1. Questionnaire with English translation). For internal validation, the questionnaire was evaluated by the authors.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>9585</offset><text>2.3. Detection of Anti-SARS-CoV-2 Antibodies</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9630</offset><text>Serum samples were screened for antibodies against the nucleocapsid (N protein) of SARS-CoV-2 using a commercial and already validated multi-species indirect ELISA (ID Screen®, ID.Vet, Grabels, France). The N protein recombinant antigen enables the detection of SARS-CoV-2-specific antibodies in sera, irrespective of their isotype. Testing was performed following the manufacturer’s instructions. Briefly, 25 µL of serum samples and positive and negative controls were diluted in dilution buffer (1:2) and analyzed in duplicate. Optical density (OD) was measured at a wavelength of 450 nm on a microplate reader MB 580 (Heales, Shenzhen Huisong Technology Development Co., Ltd., Shenzhen, China). For each sample, S/P% was calculated as follows: (ODSample-ODNegative Control)/(ODPositive Control-ODNegative Control) × 100, with serum samples presenting S/P% ≥ 60% being considered as positive, between 49% and 59% considered doubtful, and ≤50% considered negative. Reported sensitivity and specificity was 100%. Internal validation from ID.Vet reported a specificity of 98.9% (n = 92) for cats. </text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>10736</offset><text>2.4. Data Processing and Statistical Analysis</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>10782</offset><text>Data collected from Google Forms® and serologic analyses were downloaded into a database (Microsoft Excel 2016®; Microsoft Corp., Redmond, WA, USA). Statistical analysis was performed with SPSS v.27.0 (IBM Corp., Armonk, NY, USA, 2020). Descriptive statistics were used to analyze data. Odds ratio was calculated to evaluate the association between cat exposure to human COVID-19 cases and the presence of antibodies against SARS-CoV-2.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11221</offset><text>Homes where at least one person tested positive for SARS-CoV-2 were classified as COVID-19-positive households, and those without confirmed human cases of COVID-19 were classified as COVID-19-negative households.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_2</infon><offset>11434</offset><text>2.5. Ethical Approval </text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>11457</offset><text>The questionnaire was approved by the ethics committee of the Instituto Politécnico de Viseu (IPV), Viseu, Portugal. Animal sampling was approved by the committee for Animal Welfare (ORBEA) of IPV. Written consent from each owner was collected after they were informed about the study.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>11744</offset><text>3. Results</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>11755</offset><text>3.1. Geographic Distribution of the Sampled Cats</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11804</offset><text>A total of 176 cats, belonging to 94 different households, were sampled. Serum samples were obtained from 10 (of the 18) districts of mainland Portugal, although most were collected in the districts of Porto (44.9%) and Braga (26.7%) in the North Region of Portugal. In total, 3 out of 176 cats (1.7%, 95% confidence interval: 0.35–4.9) tested positive for antibodies against SARS-CoV-2, one from Porto, another from Braga, and another from the district of Évora, located in the south, in Alentejo region. Most serum samples (65.0%) were obtained between June and August 2021, although the collection period was extended until the end of October 2021. Of the 10 districts investigated, there was a greater number of human COVID-19 cases in the districts of Porto and Braga at the end of the serum sample collection period (Figure 1). </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12642</offset><text>The number of sampled cats by household was variable, but in most of the households (79.8%) only one cat was screened. In 10.6%, 2.1%, 2.1%, and 1.1% of the households, two, three, four, and five cats were sampled, respectively. In four households, it was possible to collect blood from 10, 13, 16, and 21 cats during veterinary medical care provided at home. </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>13003</offset><text>3.2. Characterization of Households </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13040</offset><text>Background information about 94 households was obtained using an online questionnaire, including cat owner sex, age, educational qualification, professional activity, and district of residence. Collected information also allowed the characterization of the household, including human members and pets (Table 1).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>13352</offset><text>COVID-19-Positive Households</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13381</offset><text>In total, 20 (21.3%) households reported at least one confirmed case of human COVID-19 and were classified as positive households. Specifically, fifteen cat owners (16.0%) were diagnosed with COVID-19, and in 18 (19.1%) households, other human members were diagnosed with COVID-19. According to owners, the diagnoses of human COVID-19 cases were performed by RT-qPCR from nasopharyngeal or oropharyngeal swabs (90.0%), blood collection for serology (5.0%), or rapid antigen test from nasopharyngeal or oropharyngeal swab (5.0%). Human COVID-19 diagnoses were carried out after January 2021 (55.0%), between October and December 2020 (35.0%), and between April and September 2020 (10.0%). </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14070</offset><text>COVID-19-positive households lived in Porto (45.0%), Aveiro (10.0%), Viseu (10.0%), Setúbal (10.0%), Évora (10.0%), Braga (5.0%), Beja (5.0%), and Faro (5.0%) districts. Of the 176 sampled cats, 136 (77.3%) belonged to COVID-19-negative households and 40 (22.7%) to COVID-19-positive households. The prevalence of seropositivity in cats from COVID-19-positive households was 5.0% (2/40) and from COVID-19-negative households was 0.7% (1/136), which correspond to an odds ratio of 7.2 (Figure 2). </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>14569</offset><text>3.3. Characterization of Cats </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14600</offset><text>Background information on the 176 cats was obtained using an online questionnaire that allowed the full characterization of animals, including signalment, environment, clinical status (appearance of clinical signs or behavioral changes during COVID-19 pandemic), and human–animal interaction before pandemic and after the diagnoses of COVID-19 human cases in the household. According to their owners, only 22 cats had chronic diseases, and 9 of them received medication. Owners of 31 cats recognized behavioral changes (21/31) or clinical signs (10/31) in their cats during the COVID-19 pandemic (Table 2).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>15209</offset><text>SARS-CoV-2-Seropositive Cats</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15238</offset><text>ELISA testing of the three SARS-CoV-2-seropositive cats presented S/P% of 136.7343 (OD = 1.7203), 242.0433 (OD = 2.3851), and 145.144 (OD = 1.7498). S/P% mean ± standard deviation of seropositive cats was 174.6405 ± 58.5237 (OD = 1.9517 ± 0.3756), while S/P% of seronegative cats was 3.3105 ± 4.8963 (OD= 0.1589 ± 0.0539). No cats tested doubtful. OD mean ± standard deviation of negative controls was 0.1400 ±0.0369 and of positive controls was 1.2010 ± 0.0994 (Figure 3, Supplementary Materials File S1). </text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15754</offset><text>SARS-CoV-2-seropositive cats were neutered or sterilized, had an indoor or mixed indoor/outdoor lifestyle, and cohabited with other animal species. Owners of Cat 1 and Cat 2 stated that they established close and frequent interaction with their cats and that after the diagnoses of human COVID-19 cases, household members maintained the same type and frequency of contact with cats. Owners did not notice clinical signs (respiratory, gastrointestinal, conjunctivitis, or others) or behavior changes. Cat 3 was infected with Feline Immunodeficiency Virus (FIV), had a basal cell carcinoma, and received corticosteroids for a long time (Table 3).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16399</offset><text>The owners of two SARS-CoV-2-seropositive cats (Cat 1 and Cat 2) and other human members of the households were diagnosed COVID-19-positive by RT-qPCR between October 2020 and January 2021 (it was not possible to determine the exact date). Four cats from the Cat 1 household were screened for antibodies against SARS-CoV-2, but none tested positive. Although there were other pets (dogs and another cat) in the Cat 2 household, only Cat 2 was tested. The COVID-19-negative household of Cat 3 had other pets (cats, dogs, and birds), but only Cat 3 was screened for anti-SARS-CoV-2 antibodies. The time interval between COVID-19 diagnoses in the household human members of Cat 1 and date of Cat 1 blood sampling was eight months. It was not possible to obtain the exact diagnose dates of COVID-19 human cases in Cat 2 and Cat 3 households. </text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>17238</offset><text>4. Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>17252</offset><text>A considerable number of studies indicated that domestic cats are highly susceptible to experimental and natural SARS-CoV-2 infection. Cats are one of the most popular companion animals and often establish close contact with humans. Although variable, the interaction between domestic cats and humans can be as close as sleeping in the same bed and licking the owner’s face. </text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>17630</offset><text>There are approximately 1.4 million domestic cats in Portuguese homes that are kept, in most cases, permanently indoor. Most Portuguese owners establish daily contact with their cats, such as playing, petting, and grooming. Therefore, the susceptibility of domestic cats to SARS-CoV-2 under natural conditions must be investigated to make reasoned recommendations regarding the management of cats in SARS-CoV-2-positive households.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>18062</offset><text>Previous studies have found a low prevalence of SARS-CoV-2-positive cats by RT-qPCR, but serological studies have revealed higher seroprevalences. Thus, serological tests seem to be preferred when the objective is to determine SARS-CoV-2 exposure in companion animals. However, as cats can be infected by FCoV, another coronavirus genetically distinct from SARS-CoV-2, the possibility of cross-reactions has been raised. Some studies employing indirect ELISA assay based on the receptor-binding domain (RBD) of SARS-CoV-2, along with a multiplex microsphere immunoassay based on nucleoprotein and spike (S) subunit 1 and 2, have already ruled out serological cross-reactivity of FCoV-specific antibodies with SARS-CoV-2, reinforcing the usefulness of serological methods to identify exposure to SARS-CoV-2. Furthermore, a study using the same commercial ELISA assay based on N protein that was employed in the present study reported a sensitivity and specificity of 100%, and the manufacturer internal validation report reported a specificity of 98.9%, confirming the ability of the ID Screen® ELISA assay to discriminate between anti-SARS-CoV-2 and anti-FCoV antibodies.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>19235</offset><text>In this study, we determined anti-SARS-CoV-2 seroprevalence in a sample of 176 cats belonging to 94 households of mainland Portugal, although most samples were obtained in the districts of Porto and Braga in the North Region. The restrictions imposed by the pandemic concerning the movement of people and the functioning of veterinary centers may justify the poor adherence of veterinary centers to the study and the need to extend the serum sample collection period. On the other hand, the uncertainty about the role of companion animals in the spread of the virus and the news of euthanasia and abandonment of thousands of pets may have discouraged veterinary practitioners from approaching the topic and inviting cat owners to participate in the study. However, the collection of background information about cats and human household members allowed the complete characterization of households, namely the human–animal interaction and the COVID-19 status of the households, which represents an advantage of the present study.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>20266</offset><text>Published serological studies have shown distinct seropositivities in companion animals related to human infection. In our study, performed on a sample of cats presented for routine veterinary consultation, the overall seroprevalence was 1.7%. Serum sample collection took place between November 2020 and October 2021, although most samples were collected between June and August 2021. At the end of October 2021, when the collection of serum samples ended, the cumulative number of cases of human COVID-19 in Portugal was 1.09 million. Seropositivity found in this study is slightly higher than the seroprevalence (0.69%) found in the first large-scale survey conducted in Germany from April to September 2020, a period when the incidence of human COVID-19 in the country was still rather low, and also higher than the seroprevalence (0.36%) obtained in a large-scale survey conducted in Thailand from April to December 2020. The low seroprevalences observed in some studies, including ours, may be related to the prevalence of SARS-CoV-2 human infection registered before cat sample collection. Indeed, the time interval between SARS-CoV-2 cat infection and sample collection is decisive, since while variable, antibody persistence seems to not be lasting, as will be discussed later. </text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>21554</offset><text>On the other hand, the characteristics of the immune response developed by some SARS-CoV-2-infected cats may, in part, justify low seroprevalences observed. The absence of seroconversion was already demonstrated for humans and cats. As suggested for SARS-CoV-2-infected humans, the absence of seroconversion may occur in some relatively mild infections, where the immune response is restricted to the respiratory tract mucosal cells and is dominated by the secretion of IgA with limited IgG production. On the other hand, exposure to SARS-CoV-2 may induce T-cell-mediated specific immune response, without activation of B-cells, as suggested for humans.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>22208</offset><text>However, the seroprevalence obtained in the present work was much lower compared with the seroprevalence obtained in another Portuguese study (21.7%), which collected samples from 69 cats between December 2020 and May 2021, mainly in the district of Braga (56 cats). While samples in that study were collected in veterinary centers (hospitals, clinics) and shelters, in our study, all sera samples were obtained in veterinary centers. However, apparently, the most appreciable difference between the two studies was the ELISA assay employed. While samples in our study were screened using a commercial ELISA based on SARS-CoV-2 N protein, Barroso and colleagues used an in-house ELISA assay based on RBD of SARS-CoV-2. The sensitivities of the two ELISA assays may be different due to specific antibody responses raised against the viral N protein and directed against the RBD of S antigens. Indeed, a population-based study showed that antibody responses against viral S and N proteins are equally sensitive in the acute phase of infection, but while response against N decreases in the post-infection phase, the response against the S protein persists. Thus, it is probable that our study underestimate seroprevalence, as previously reported.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23453</offset><text>This study included 94 households from 10 out 12 districts of mainland Portugal. A higher number of households from the districts of Braga, Porto, and Évora were investigated. Of the 10 districts surveyed, there was a greater number of human COVID-19 cases in the districts of Porto and Braga at the end of the serum sample collection period. Not surprisingly, the three SARS-CoV-2-seropositive cats were identified in these three districts.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23896</offset><text>Considering COVID-19 status, our study included 20 negative and 76 positive households. Of the three seropositive cats identified in this study, two belonged to COVID-19-positive households, and one cat lived in a COVID-19-negative household. Thus, the seropositivity observed in cats from COVID-19-positive households was 5.0% and in cats from COVID-19-negative households was 0.7%. Several studies have already reported the infection of cats following natural exposure to infected people. In line with this, high seropositivities were observed in cats living in COVID-19-positive households. Recently, a longitudinal study, including 39 pets (29 dogs and 10 cats) living with human COVID-19 patients, identified close human–animal contact, such as sharing a bed with an owner with COVID-19, as the main risk factor for infection of the co-inhabiting animals. As such, we hypothesize that the most likely source of infection of the two seropositive cats from COVID-19-positive households identified in this study was the contact with human infected members (“reverse zoonosis”). Indeed, both cats had an exclusively indoor lifestyle, which limits the possibility of infection in another environment, and according to owners, animals established close and frequent contact with humans, increasing the opportunities for virus spillover and infection. </text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25253</offset><text>However, the source of infection of the cat belonging to the COVID-19-negative household is more difficult to identify, although some hypotheses may be raised. As this cat had a mixed indoor/outdoor lifestyle, there are the possibilities of infection via SARS-CoV-2 environmental contamination or cat-to-cat transmission. Reports of SARS-CoV-2-seropositive stray cats demonstrate the role of cat-to-cat transmission and/or environmental contamination as potential sources of SARS-CoV-2 infection. Furthermore, cat-to-cat transmission in natural conditions is consistent with experimental studies that proved virus transmission from infected to naive cats via the airborne route. Contact with COVID-19 asymptomatic human household members or other COVID-19 human patients is also a possibility. Meanwhile, other studies had already reported the presence of seropositive cats living in COVID-19-negative households, including those without outdoor access. </text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>26208</offset><text>Determination of antibody longevity is crucial to evaluate humoral response to SARS-CoV-2 under natural conditions. Experimental studies determined that cats seroconverted 7 to 14 days post-infection; however, the duration of antibodies is variable. One cat tested twice three months apart turned seronegative in the second test, suggesting that longevity of anti-SARS-CoV-2 antibodies may not be lasting. In the present study, one cat tested positive eight months after the diagnoses of COVID-19 in human household members, suggesting longer antibody longevity. Antibodies against SARS-CoV-2 were identified in an Italian cat living in a COVID-19-affected household six months after being tested positive by RT-qPCR, indicating the persistence of humoral immunity for long time. </text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>26989</offset><text>One of three seropositive cats identified in this study was co-infected with FIV. Viral co-infection was already reported in other studies and may play an important role in the susceptibility and clinical outcomes of SARS-CoV-2-infected cats. However, in this study, all SARS-CoV-2-seropositive cats, including the FIV-co-infected, were apparently asymptomatic, as their owners did not notice any clinical sign or behavioral change. This finding contrast with some studies where the percentage of symptomatic cats was high, such as the mortality in. Probably, the nonspecific, mild, and reversible character of the clinical signs associated with COVID-19 in companion animals prevented the recognition of the disease by cat owners. Thus, cats may act as silent hosts of SARS-CoV-2, as they may not show appreciable clinical signs, as previously reported by other authors. </text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>27862</offset><text>Non-infectious comorbidities such as hypertension, heart diseases, obesity, chronic kidney and respiratory diseases, diabetes mellitus, and cancer were shown to increase the risk of the development of severe disease in humans with COVID-19. The presence of non-infectious comorbidities, such as intestinal B-cell lymphoma and hypertrophic cardiomyopathy, was also reported in SARS-CoV-2-infected cats, and it was associated with moderate, severe, or even fatal disease. Despite the clinical condition of Cat 3, in whom the presence of FIV infection was associated with a neoplasm (basal cell carcinoma), the owners did not notice the presence of clinical signs. It can be speculated that the chronic administration of corticosteroids to this cat may have contributed to decreasing the inflammation associated with SARS-CoV-2 infection and the manifestation of clinical signs, although the beneficial effect of this drug in humans with COVID-19 is controversial.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>28824</offset><text>Furthermore, SARS-CoV-2 variants may affect viral transmissibility, virulence, and consequently the severity and lethality of the infection, as occurs in humans. At least five SARS-CoV-2 variants of concerns (VOC) have been classified by WHO, including the Alpha variant (B.1.1.7), Beta variant (B.1.351), Gamma variant (P.1), Delta variant (B.1.617.2), and Omicron (B.1.1.529). Alpha variant was isolated from cats with clinical conditions of varying severity, from asymptomatic, mild disease, characterized by sneezing, to severe conditions characterized by dyspnea and fever or acute myocarditis. The SARS-CoV-2 Gamma variant was identified as a cause of death of a FeLV-positive cat presenting severe acute respiratory syndrome and lesions in several organs. The Delta variant was isolated from three cats from Harbin and from a cat with history of anorexia, lethargy, soft stools, and vomiting. Although it would be interesting to investigate the clinical picture exhibited by cats infected by different SARS-CoV-2 variants, the small number of viral genomes isolated and sequenced so far does not allow the establishment of an association between disease severity and SARS-CoV-2 variant in this species. Furthermore, we were not able to obtain information about SARS-CoV-2 infecting variant of COVID-19 human members.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>30148</offset><text>Despite the apparent low risk of infection of cats living in households diagnosed with COVID-19, it is advisable to follow the recommendation of the European Advisory Board on Cat Diseases, namely keeping the cats indoors during quarantine and performing human–animal interactions under basic hygienic measures.</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>30462</offset><text>5. Conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>30477</offset><text>This study highlights the low risk of SARS-CoV-2 transmission from COVID-19-positive human household members to domestic cats, even in a context of close and frequent human–animal contact. </text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">footnote</infon><offset>30669</offset><text>Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>30795</offset><text>Supplementary Materials</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>30819</offset><text>The following supporting information can be downloaded at: , File S1: Optical densities obtained in the SARS-CoV-2 ELISA assay in the sampled cats.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title</infon><offset>30967</offset><text>Author Contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>30988</offset><text>Conceptualization, H.V., T.L.M. and M.A.P.; methodology, H.V., M.A.P. and T.L.M.; validation, A.O., M.A.P., T.L.M., J.R.M. and H.V.; formal analysis, A.O. and M.A.P.; investigation, A.O. and M.A.P.; writing—original draft preparation, A.O. and M.A.P.; writing—review and editing, M.A.P., T.L.M. and J.R.M.; supervision, M.A.P., T.L.M. and H.V.; project administration, H.V.; funding acquisition, M.A.P. All authors have read and agreed to the published version of the manuscript.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title</infon><offset>31472</offset><text>Institutional Review Board Statement</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>31509</offset><text>The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Committee for Animal Welfare of the Instituto Politécnico de Viseu (IPV) (01/ORBEA/2021, 30 April 2021).</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title</infon><offset>31718</offset><text>Informed Consent Statement</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>31745</offset><text>Informed consent was obtained from all cat owners involved in the study.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title</infon><offset>31818</offset><text>Data Availability Statement</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>31846</offset><text>The data presented in this study are available in Supplementary Materials.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title</infon><offset>31921</offset><text>Conflicts of Interest</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>31943</offset><text>The authors declare no conflict of interest.</text></passage><passage><infon key="section_type">APPENDIX</infon><infon key="type">title</infon><offset>31988</offset><text>Appendix A</text></passage><passage><infon key="file">vetsci-09-00363-t0A1.xml</infon><infon key="id">vetsci-09-00363-t0A1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>31999</offset><text>Questionnaire applied to cat owners.</text></passage><passage><infon key="file">vetsci-09-00363-t0A1.xml</infon><infon key="id">vetsci-09-00363-t0A1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Topics&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Question&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Options&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Type of Question&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td rowspan=&quot;11&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; colspan=&quot;1&quot;&gt;Owner’s information&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Owner’s gender&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Male/Female/I don’t want to answer&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Owner’s age&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;From 18 to 30 years old/From 30 to 50 years old/From 50 to 70 years old/Over 70 years old&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Owner’s actual residence&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Viana do Castelo/Braga/Vila Real/Bragança/Porto/Aveiro/Viseu&lt;break/&gt;Guarda/Coimbra/Castelo Branco&lt;break/&gt;Leiria/Lisboa/Santarém/Portalegre&lt;break/&gt;Setubal/Évora/Beja/Faro&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;City of residence&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Open-ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Owner’s academic qualifications&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Elementary School (1st Cycle)&lt;break/&gt;Elementary School (2nd Cycle)&lt;break/&gt;Elementary School (3rd Cycle)&lt;break/&gt;Secondary Education/Graduation&lt;break/&gt;Bachelor’s degree/Master’s Degree&lt;break/&gt;PhD (Doctorate)/Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Owner’s professional activity&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Student/Employed/Unemployed&lt;break/&gt;Retired&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Number of members in the household&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Open-ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Do you have other pets?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes/No&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dichotomic&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;If the answer is yes, please list the species&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dog/Cat/Ferret/Birds/Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;How does the household normally interact with your cat?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Not much interaction (feeding, watering, cleaning the cat’s litter box)/Playing, petting, and cuddling/Resting on the lap/Sharing the bed/Sharing the sofa/Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;How often do you usually give attention to the cat?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;All day long/During a part of the day, e.g., in the evening/Only in some moments of the day/We do not usually provide any attention to the cat/Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;13&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; colspan=&quot;1&quot;&gt;Cat&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Status&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Non-neutered/Non-spayed/Neutered/Spayed&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gender&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Female/Male&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dichotomic&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Age&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Under 1 year/From 1 to 5 years/From 5 to 10 years/More than 10 years&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Breed&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Persian/Maine Coon/Siamese/Scottish Fold/Norwegian Forest/British Shorthair/Bengal/ European Shorthaired /Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Is the cat mainly indoor (stays inside) or outdoor (have access to the road)?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Indoor/Outdoor/Indoor and Outdoor&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Do you usually vaccinate your cat once a year?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes/No&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dichotomic&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;What about deworming? How often do you do it?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Every 3 months/Every 6 months/Every year/When possible/I do not usually do it&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Did your pet show any unusual clinical signs and/or behavior change since the beginning of the pandemic?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes/No&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;If the answer is yes, please specify which ones&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Respiratory disease (coughing, runny nose, sneezing, runny eyes, dyspnea)/Apathy/ Fever/Digestive disorders (diarrhea, vomiting)/Skin problems/Loss of weight/&lt;break/&gt;Loss of appetite/Behavioral disorders/ Conjunctivitis/Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Does your animal present any chronic disease?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes/No/I don’t know&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;If the answer is yes, which one/what one?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Diabetes/Kidney/hepatic disease/Joint disease/ FIV/FeLV/Heart disease/Hypothyroidism&lt;break/&gt;/Gingivostomatitis/Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;If the answer is yes, is monitoring therapy performed for that chronic disease?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes/No&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dichotomic&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;If the answer is yes, what is the name of the medicine?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Open-ended&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;5&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; colspan=&quot;1&quot;&gt;COVID-19&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Has the owner been diagnosed for COVID-19?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes/No&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dichotomic&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Has another member of your household been diagnosed with COVID-19?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes/No&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dichotomic&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;How was the diagnosis performed for COVID-19?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;With nasopharyngeal or oropharyngeal swab for PCR test/With nasopharyngeal or oropharyngeal swab for rapid test/With blood sampling for serological test (antibodies)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;During which period(s) did you obtain positive test(s)? You can select more than one option:&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1st wave (April 2020-September 2020)/2nd wave (October 2020-December 2020)/3rd wave (from January 2021)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;During the time when the household member was living with COVID-19, did he/she interact with the cat?&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;As usual/Reduced interactions/Reduced interactions and used protection (mask, gloves) while interacting/Did not interact/Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Multiple choice&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>32036</offset><text>Topics	Question	Options	Type of Question	 	Owner’s information	Owner’s gender	Male/Female/I don’t want to answer	Multiple choice	 	Owner’s age	From 18 to 30 years old/From 30 to 50 years old/From 50 to 70 years old/Over 70 years old	Multiple choice	 	Owner’s actual residence	Viana do Castelo/Braga/Vila Real/Bragança/Porto/Aveiro/ViseuGuarda/Coimbra/Castelo BrancoLeiria/Lisboa/Santarém/PortalegreSetubal/Évora/Beja/Faro	Multiple choice	 	City of residence		Open-ended	 	Owner’s academic qualifications	Elementary School (1st Cycle)Elementary School (2nd Cycle)Elementary School (3rd Cycle)Secondary Education/GraduationBachelor’s degree/Master’s DegreePhD (Doctorate)/Other	Multiple choice	 	Owner’s professional activity	Student/Employed/UnemployedRetired	Multiple choice	 	Number of members in the household		Open-ended	 	Do you have other pets?	Yes/No	Dichotomic	 	If the answer is yes, please list the species	Dog/Cat/Ferret/Birds/Other	Multiple choice	 	How does the household normally interact with your cat?	Not much interaction (feeding, watering, cleaning the cat’s litter box)/Playing, petting, and cuddling/Resting on the lap/Sharing the bed/Sharing the sofa/Other	Multiple choice	 	How often do you usually give attention to the cat?	All day long/During a part of the day, e.g., in the evening/Only in some moments of the day/We do not usually provide any attention to the cat/Other	Multiple choice	 	Cat	Status	Non-neutered/Non-spayed/Neutered/Spayed	Multiple choice	 	Gender	Female/Male	Dichotomic	 	Age	Under 1 year/From 1 to 5 years/From 5 to 10 years/More than 10 years	Multiple choice	 	Breed	Persian/Maine Coon/Siamese/Scottish Fold/Norwegian Forest/British Shorthair/Bengal/ European Shorthaired /Other	Multiple choice	 	Is the cat mainly indoor (stays inside) or outdoor (have access to the road)?	Indoor/Outdoor/Indoor and Outdoor	Multiple choice	 	Do you usually vaccinate your cat once a year?	Yes/No	Dichotomic	 	What about deworming? How often do you do it?	Every 3 months/Every 6 months/Every year/When possible/I do not usually do it	Multiple choice	 	Did your pet show any unusual clinical signs and/or behavior change since the beginning of the pandemic?	Yes/No	Multiple choice	 	If the answer is yes, please specify which ones	Respiratory disease (coughing, runny nose, sneezing, runny eyes, dyspnea)/Apathy/ Fever/Digestive disorders (diarrhea, vomiting)/Skin problems/Loss of weight/Loss of appetite/Behavioral disorders/ Conjunctivitis/Other	Multiple choice	 	Does your animal present any chronic disease?	Yes/No/I don’t know	Multiple choice	 	If the answer is yes, which one/what one?	Diabetes/Kidney/hepatic disease/Joint disease/ FIV/FeLV/Heart disease/Hypothyroidism/Gingivostomatitis/Other	Multiple choice	 	If the answer is yes, is monitoring therapy performed for that chronic disease?	Yes/No	Dichotomic	 	If the answer is yes, what is the name of the medicine?		Open-ended	 	COVID-19	Has the owner been diagnosed for COVID-19?	Yes/No	Dichotomic	 	Has another member of your household been diagnosed with COVID-19?	Yes/No	Dichotomic	 	How was the diagnosis performed for COVID-19?	With nasopharyngeal or oropharyngeal swab for PCR test/With nasopharyngeal or oropharyngeal swab for rapid test/With blood sampling for serological test (antibodies)	Multiple choice	 	During which period(s) did you obtain positive test(s)? You can select more than one option:	1st wave (April 2020-September 2020)/2nd wave (October 2020-December 2020)/3rd wave (from January 2021)	Multiple choice	 	During the time when the household member was living with COVID-19, did he/she interact with the cat?	As usual/Reduced interactions/Reduced interactions and used protection (mask, gloves) while interacting/Did not interact/Other	Multiple choice	 	</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>35832</offset><text>References</text></passage><passage><infon key="fpage">108693</infon><infon key="name_0">surname:Decaro;given-names:N.</infon><infon key="name_1">surname:Lorusso;given-names:A.</infon><infon key="pub-id_doi">10.1016/j.vetmic.2020.108693</infon><infon key="pub-id_pmid">32402329</infon><infon key="section_type">REF</infon><infon key="source">Vet. Microbiol.</infon><infon key="type">ref</infon><infon key="volume">244</infon><infon key="year">2020</infon><offset>35843</offset><text>Novel human coronavirus (SARS-CoV-2): A lesson from animal coronaviruses</text></passage><passage><infon key="fpage">2305</infon><infon key="lpage">2320</infon><infon key="name_0">surname:Valencak;given-names:T.G.</infon><infon key="name_1">surname:Csiszar;given-names:A.</infon><infon key="name_2">surname:Szalai;given-names:G.</infon><infon key="name_3">surname:Podlutsky;given-names:A.</infon><infon key="name_4">surname:Tarantini;given-names:S.</infon><infon key="name_5">surname:Fazekas-Pongor;given-names:V.</infon><infon key="name_6">surname:Papp;given-names:M.</infon><infon key="name_7">surname:Ungvari;given-names:Z.</infon><infon key="pub-id_doi">10.1007/s11357-021-00444-9</infon><infon key="pub-id_pmid">34460063</infon><infon key="section_type">REF</infon><infon key="source">GeroScience</infon><infon key="type">ref</infon><infon key="volume">43</infon><infon key="year">2021</infon><offset>35916</offset><text>Animal reservoirs of SARS-CoV-2: Calculable COVID-19 risk for older adults from animal to human transmission</text></passage><passage><infon key="fpage">11779322211025876</infon><infon key="name_0">surname:Gorkhali;given-names:R.</infon><infon key="name_1">surname:Koirala;given-names:P.</infon><infon key="name_2">surname:Rijal;given-names:S.</infon><infon key="name_3">surname:Mainali;given-names:A.</infon><infon key="name_4">surname:Baral;given-names:A.</infon><infon key="name_5">surname:Bhattarai;given-names:H.K.</infon><infon key="pub-id_doi">10.1177/11779322211025876</infon><infon key="pub-id_pmid">34220199</infon><infon key="section_type">REF</infon><infon key="source">Bioinform. Biol. Insights</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2021</infon><offset>36025</offset><text>Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins</text></passage><passage><infon key="fpage">450</infon><infon key="lpage">452</infon><infon key="name_0">surname:Andersen;given-names:K.G.</infon><infon key="name_1">surname:Rambaut;given-names:A.</infon><infon key="name_2">surname:Lipkin;given-names:W.I.</infon><infon key="name_3">surname:Holmes;given-names:E.C.</infon><infon key="name_4">surname:Garry;given-names:R.F.</infon><infon key="pub-id_doi">10.1038/s41591-020-0820-9</infon><infon key="pub-id_pmid">32284615</infon><infon key="section_type">REF</infon><infon key="source">Nat. Med.</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2020</infon><offset>36090</offset><text>The proximal origin of SARS-CoV-2</text></passage><passage><infon key="fpage">100133</infon><infon key="name_0">surname:Leroy;given-names:E.M.</infon><infon key="name_1">surname:Gouilh;given-names:M.A.</infon><infon key="name_2">surname:Brugère-Picoux;given-names:J.</infon><infon key="pub-id_doi">10.1016/j.onehlt.2020.100133</infon><infon key="pub-id_pmid">32363229</infon><infon key="section_type">REF</infon><infon key="source">One Health</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2020</infon><offset>36124</offset><text>The risk of SARS-CoV-2 transmission to pets and other wild and domestic animals strongly mandates a one-health strategy to control the COVID-19 pandemic</text></passage><passage><infon key="fpage">2006</infon><infon key="lpage">2011</infon><infon key="name_0">surname:Kannan;given-names:S.</infon><infon key="name_1">surname:Shaik Syed Ali;given-names:P.</infon><infon key="name_2">surname:Sheeza;given-names:A.</infon><infon key="name_3">surname:Hemalatha;given-names:K.</infon><infon key="pub-id_doi">10.26355/eurrev_202002_20378</infon><infon key="pub-id_pmid">32141569</infon><infon key="section_type">REF</infon><infon key="source">Eur. Rev. Med. Pharmacol. Sci.</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">2020</infon><offset>36277</offset><text>COVID-19 (Novel Coronavirus 2019)—Recent trends</text></passage><passage><infon key="fpage">e00127-20</infon><infon key="name_0">surname:Wan;given-names:Y.</infon><infon key="name_1">surname:Shang;given-names:J.</infon><infon key="name_2">surname:Graham;given-names:R.</infon><infon key="name_3">surname:Baric;given-names:R.S.</infon><infon key="name_4">surname:Li;given-names:F.</infon><infon key="pub-id_doi">10.1128/JVI.00127-20</infon><infon key="pub-id_pmid">31996437</infon><infon key="section_type">REF</infon><infon key="source">J. Virol.</infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">2020</infon><offset>36327</offset><text>Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus</text></passage><passage><infon key="elocation-id">848</infon><infon key="name_0">surname:Prata;given-names:J.C.</infon><infon key="pub-id_doi">10.3390/ani10050848</infon><infon key="section_type">REF</infon><infon key="source">Animals</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2020</infon><offset>36457</offset><text>Strategies for the Improvement of Pet Health and Welfare in Portugal Based on a Pilot Survey on Husbandry, Opinion, and Information Needs</text></passage><passage><infon key="elocation-id">3789</infon><infon key="name_0">surname:Overgaauw;given-names:P.A.M.</infon><infon key="name_1">surname:Vinke;given-names:C.M.</infon><infon key="name_2">surname:van Hagen;given-names:M.A.</infon><infon key="name_3">surname:Lipman;given-names:L.J.</infon><infon key="pub-id_doi">10.3390/ijerph17113789</infon><infon key="section_type">REF</infon><infon key="source">Int. J. Environ. Res. Public Health</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2020</infon><offset>36595</offset><text>A One Health Perspective on the Human–Companion Animal Relationship with Emphasis on Zoonotic Aspects</text></passage><passage><infon key="fpage">74</infon><infon key="lpage">81</infon><infon key="name_0">surname:Bell;given-names:E.T.</infon><infon key="name_1">surname:Toribio;given-names:J.A.</infon><infon key="name_2">surname:White;given-names:J.D.</infon><infon key="name_3">surname:Malik;given-names:R.</infon><infon key="name_4">surname:Norris;given-names:J.M.</infon><infon key="pub-id_doi">10.1111/j.1751-0813.2006.tb12231.x</infon><infon key="pub-id_pmid">16555552</infon><infon key="section_type">REF</infon><infon key="source">Aust. Vet. J.</infon><infon key="type">ref</infon><infon key="volume">84</infon><infon key="year">2006</infon><offset>36699</offset><text>Seroprevalence study of feline coronavirus in owned and feral cats in Sydney, Australia</text></passage><passage><infon key="fpage">1209</infon><infon key="lpage">1215</infon><infon key="name_0">surname:Kummrow;given-names:M.</infon><infon key="name_1">surname:Meli;given-names:M.L.</infon><infon key="name_2">surname:Haessig;given-names:M.</infon><infon key="name_3">surname:Goenczi;given-names:E.</infon><infon key="name_4">surname:Poland;given-names:A.</infon><infon key="name_5">surname:Pedersen;given-names:N.C.</infon><infon key="name_6">surname:Hofmann-Lehmann;given-names:R.</infon><infon key="name_7">surname:Lutz;given-names:H.</infon><infon key="pub-id_doi">10.1128/CDLI.12.10.1209-1215.2005</infon><infon key="pub-id_pmid">16210485</infon><infon key="section_type">REF</infon><infon key="source">Clin. Diagn. Lab. Immunol.</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2005</infon><offset>36787</offset><text>Feline coronavirus serotypes 1 and 2: Seroprevalence and association with disease in Switzerland</text></passage><passage><infon key="fpage">1445</infon><infon key="lpage">1452</infon><infon key="name_0">surname:Brown;given-names:M.A.</infon><infon key="name_1">surname:Troyer;given-names:J.L.</infon><infon key="name_2">surname:Pecon-Slattery;given-names:J.</infon><infon key="name_3">surname:Roelke;given-names:M.E.</infon><infon key="name_4">surname:O’Brien;given-names:S.J.</infon><infon key="pub-id_doi">10.3201/eid1509.081573</infon><infon key="pub-id_pmid">19788813</infon><infon key="section_type">REF</infon><infon key="source">Emerg. Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2009</infon><offset>36884</offset><text>Genetics and pathogenesis of feline infectious peritonitis virus</text></passage><passage><infon key="fpage">270</infon><infon key="lpage">273</infon><infon key="name_0">surname:Zhou;given-names:P.</infon><infon key="name_1">surname:Yang;given-names:X.L.</infon><infon key="name_2">surname:Wang;given-names:X.G.</infon><infon key="name_3">surname:Hu;given-names:B.</infon><infon key="name_4">surname:Zhang;given-names:L.</infon><infon key="name_5">surname:Zhang;given-names:W.</infon><infon key="name_6">surname:Si;given-names:H.R.</infon><infon key="name_7">surname:Zhu;given-names:Y.</infon><infon key="name_8">surname:Li;given-names:B.</infon><infon key="name_9">surname:Huang;given-names:C.L.</infon><infon key="pub-id_doi">10.1038/s41586-020-2012-7</infon><infon key="pub-id_pmid">32015507</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">579</infon><infon key="year">2020</infon><offset>36949</offset><text>A pneumonia outbreak associated with a new coronavirus of probable bat origin</text></passage><passage><infon key="fpage">108777</infon><infon key="name_0">surname:Stout;given-names:A.E.</infon><infon key="name_1">surname:André;given-names:N.M.</infon><infon key="name_2">surname:Jaimes;given-names:J.A.</infon><infon key="name_3">surname:Millet;given-names:J.K.</infon><infon key="name_4">surname:Whittaker;given-names:G.R.</infon><infon key="pub-id_doi">10.1016/j.vetmic.2020.108777</infon><infon key="pub-id_pmid">32768223</infon><infon key="section_type">REF</infon><infon key="source">Vet. Microbiol.</infon><infon key="type">ref</infon><infon key="volume">247</infon><infon key="year">2020</infon><offset>37027</offset><text>Coronaviruses in cats and other companion animals: Where does SARS-CoV-2/COVID-19 fit?</text></passage><passage><infon key="fpage">272</infon><infon key="lpage">292</infon><infon key="name_0">surname:Gryseels;given-names:S.</infon><infon key="name_1">surname:De Bruyn;given-names:L.</infon><infon key="name_2">surname:Gyselings;given-names:R.</infon><infon key="name_3">surname:Calvignac-Spencer;given-names:S.</infon><infon key="name_4">surname:Leendertz;given-names:F.H.</infon><infon key="name_5">surname:Leirs;given-names:H.</infon><infon key="pub-id_doi">10.1111/mam.12225</infon><infon key="section_type">REF</infon><infon key="source">Mammal Rev.</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">2020</infon><offset>37114</offset><text>Risk of human-to-wildlife transmission of SARS-CoV-2</text></passage><passage><infon key="fpage">26382</infon><infon key="lpage">26388</infon><infon key="name_0">surname:Bosco-Lauth;given-names:A.M.</infon><infon key="name_1">surname:Hartwig;given-names:A.E.</infon><infon key="name_2">surname:Porter;given-names:S.M.</infon><infon key="name_3">surname:Gordy;given-names:P.W.</infon><infon key="name_4">surname:Nehring;given-names:M.</infon><infon key="name_5">surname:Byas;given-names:A.D.</infon><infon key="name_6">surname:VandeWoude;given-names:S.</infon><infon key="name_7">surname:Ragan;given-names:I.K.</infon><infon key="name_8">surname:Maison;given-names:R.M.</infon><infon key="name_9">surname:Bowen;given-names:R.A.</infon><infon key="pub-id_doi">10.1073/pnas.2013102117</infon><infon key="pub-id_pmid">32994343</infon><infon key="section_type">REF</infon><infon key="source">Proc. Natl. Acad. Sci. USA</infon><infon key="type">ref</infon><infon key="volume">117</infon><infon key="year">2020</infon><offset>37167</offset><text>Experimental infection of domestic dogs and cats with SARS-CoV-2: Pathogenesis, transmission, and response to reexposure in cats</text></passage><passage><infon key="fpage">2322</infon><infon key="lpage">2332</infon><infon key="name_0">surname:Gaudreault;given-names:N.N.</infon><infon key="name_1">surname:Trujillo;given-names:J.D.</infon><infon key="name_2">surname:Carossino;given-names:M.</infon><infon key="name_3">surname:Meekins;given-names:D.A.</infon><infon key="name_4">surname:Morozov;given-names:I.</infon><infon key="name_5">surname:Madden;given-names:D.W.</infon><infon key="name_6">surname:Indran;given-names:S.V.</infon><infon key="name_7">surname:Bold;given-names:D.</infon><infon key="name_8">surname:Balaraman;given-names:V.</infon><infon key="name_9">surname:Kwon;given-names:T.</infon><infon key="pub-id_doi">10.1080/22221751.2020.1833687</infon><infon key="pub-id_pmid">33028154</infon><infon key="section_type">REF</infon><infon key="source">Emerg. Microbes Infect.</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2020</infon><offset>37296</offset><text>SARS-CoV-2 infection, disease and transmission in domestic cats</text></passage><passage><infon key="fpage">592</infon><infon key="lpage">594</infon><infon key="name_0">surname:Halfmann;given-names:P.J.</infon><infon key="name_1">surname:Hatta;given-names:M.</infon><infon key="name_2">surname:Chiba;given-names:S.</infon><infon key="name_3">surname:Maemura;given-names:T.</infon><infon key="name_4">surname:Fan;given-names:S.</infon><infon key="name_5">surname:Takeda;given-names:M.</infon><infon key="name_6">surname:Kinoshita;given-names:N.</infon><infon key="name_7">surname:Hattori;given-names:S.-I.</infon><infon key="name_8">surname:Sakai-Tagawa;given-names:Y.</infon><infon key="name_9">surname:Iwatsuki-Horimoto;given-names:K.</infon><infon key="pub-id_doi">10.1056/NEJMc2013400</infon><infon key="pub-id_pmid">32402157</infon><infon key="section_type">REF</infon><infon key="source">N. Engl. J. Med.</infon><infon key="type">ref</infon><infon key="volume">383</infon><infon key="year">2020</infon><offset>37360</offset><text>Transmission of SARS-CoV-2 in Domestic Cats</text></passage><passage><infon key="fpage">1016</infon><infon key="lpage">1020</infon><infon key="name_0">surname:Shi;given-names:J.</infon><infon key="name_1">surname:Wen;given-names:Z.</infon><infon key="name_2">surname:Zhong;given-names:G.</infon><infon key="name_3">surname:Yang;given-names:H.</infon><infon key="name_4">surname:Wang;given-names:C.</infon><infon key="name_5">surname:Huang;given-names:B.</infon><infon key="name_6">surname:Liu;given-names:R.</infon><infon key="name_7">surname:He;given-names:X.</infon><infon key="name_8">surname:Shuai;given-names:L.</infon><infon key="name_9">surname:Sun;given-names:Z.</infon><infon key="pub-id_doi">10.1126/science.abb7015</infon><infon key="pub-id_pmid">32269068</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">368</infon><infon key="year">2020</infon><offset>37404</offset><text>Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2</text></passage><passage><infon key="fpage">1313</infon><infon key="lpage">1321</infon><infon key="name_0">surname:Bao;given-names:L.</infon><infon key="name_1">surname:Song;given-names:Z.</infon><infon key="name_2">surname:Xue;given-names:J.</infon><infon key="name_3">surname:Gao;given-names:H.</infon><infon key="name_4">surname:Liu;given-names:J.</infon><infon key="name_5">surname:Wang;given-names:J.</infon><infon key="name_6">surname:Guo;given-names:Q.</infon><infon key="name_7">surname:Zhao;given-names:B.</infon><infon key="name_8">surname:Qu;given-names:Y.</infon><infon key="name_9">surname:Qi;given-names:F.</infon><infon key="pub-id_doi">10.1093/infdis/jiab104</infon><infon key="pub-id_pmid">33605423</infon><infon key="section_type">REF</infon><infon key="source">J. Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">223</infon><infon key="year">2021</infon><offset>37496</offset><text>Susceptibility and Attenuated Transmissibility of SARS-CoV-2 in Domestic Cats</text></passage><passage><infon key="fpage">3071</infon><infon key="lpage">3074</infon><infon key="name_0">surname:Barrs;given-names:V.R.</infon><infon key="name_1">surname:Peiris;given-names:M.</infon><infon key="name_2">surname:Tam;given-names:K.W.</infon><infon key="name_3">surname:Law;given-names:P.Y.</infon><infon key="name_4">surname:Brackman;given-names:C.J.</infon><infon key="name_5">surname:To;given-names:E.M.</infon><infon key="name_6">surname:Yu;given-names:V.Y.</infon><infon key="name_7">surname:Chu;given-names:D.K.</infon><infon key="name_8">surname:Perera;given-names:R.A.</infon><infon key="name_9">surname:Sit;given-names:T.H.</infon><infon key="pub-id_doi">10.3201/eid2612.202786</infon><infon key="pub-id_pmid">32938527</infon><infon key="section_type">REF</infon><infon key="source">Emerg. Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2020</infon><offset>37574</offset><text>SARS-CoV-2 in Quarantined Domestic Cats from COVID-19 Households or Close Contacts, Hong Kong, China</text></passage><passage><infon key="elocation-id">938</infon><infon key="name_0">surname:Hamer;given-names:S.A.</infon><infon key="name_1">surname:Pauvolid-Corrêa;given-names:A.</infon><infon key="name_2">surname:Zecca;given-names:I.</infon><infon key="name_3">surname:Davila;given-names:E.</infon><infon key="name_4">surname:Auckland;given-names:L.</infon><infon key="name_5">surname:Roundy;given-names:C.</infon><infon key="name_6">surname:Tang;given-names:W.</infon><infon key="name_7">surname:Torchetti;given-names:M.</infon><infon key="name_8">surname:Killian;given-names:M.</infon><infon key="name_9">surname:Jenkins-Moore;given-names:M.</infon><infon key="pub-id_doi">10.3390/v13050938</infon><infon key="pub-id_pmid">34069453</infon><infon key="section_type">REF</infon><infon key="source">Viruses</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2021</infon><offset>37675</offset><text>SARS-CoV-2 Infections and Viral Isolations among Serially Tested Cats and Dogs in Households with Infected Owners in Texas, USA</text></passage><passage><infon key="name_0">surname:Hosie;given-names:M.J.</infon><infon key="name_1">surname:Epifano;given-names:I.</infon><infon key="name_2">surname:Herder;given-names:V.</infon><infon key="name_3">surname:Orton;given-names:R.J.</infon><infon key="name_4">surname:Stevenson;given-names:A.</infon><infon key="name_5">surname:Johnson;given-names:N.</infon><infon key="name_6">surname:MacDonald;given-names:E.</infon><infon key="name_7">surname:Dunbar;given-names:D.</infon><infon key="name_8">surname:McDonald;given-names:M.</infon><infon key="name_9">surname:Howie;given-names:F.</infon><infon key="pub-id_doi">10.1101/2020.09.23.309948</infon><infon key="section_type">REF</infon><infon key="source">bioRxiv</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>37803</offset><text>Respiratory disease in cats associated with human-to-cat transmission of SARS-CoV-2 in the UK</text></passage><passage><infon key="fpage">2324</infon><infon key="lpage">2328</infon><infon key="name_0">surname:Sailleau;given-names:C.</infon><infon key="name_1">surname:Dumarest;given-names:M.</infon><infon key="name_2">surname:Vanhomwegen;given-names:J.</infon><infon key="name_3">surname:Delaplace;given-names:M.</infon><infon key="name_4">surname:Caro;given-names:V.</infon><infon key="name_5">surname:Kwasiborski;given-names:A.</infon><infon key="name_6">surname:Hourdel;given-names:V.</infon><infon key="name_7">surname:Chevaillier;given-names:P.</infon><infon key="name_8">surname:Barbarino;given-names:A.</infon><infon key="name_9">surname:Comtet;given-names:L.</infon><infon key="pub-id_doi">10.1111/tbed.13659</infon><infon key="pub-id_pmid">32500944</infon><infon key="section_type">REF</infon><infon key="source">Transbound. Emerg. Dis.</infon><infon key="type">ref</infon><infon key="volume">67</infon><infon key="year">2020</infon><offset>37897</offset><text>First detection and genome sequencing of SARS-CoV-2 in an infected cat in France</text></passage><passage><infon key="fpage">973</infon><infon key="lpage">976</infon><infon key="name_0">surname:Ruiz-Arrondo;given-names:I.</infon><infon key="name_1">surname:Portillo;given-names:A.</infon><infon key="name_2">surname:Palomar;given-names:A.M.</infon><infon key="name_3">surname:Santibáñez;given-names:S.</infon><infon key="name_4">surname:Santibáñez;given-names:P.</infon><infon key="name_5">surname:Cervera;given-names:C.</infon><infon key="name_6">surname:Oteo;given-names:J.A.</infon><infon key="pub-id_doi">10.1111/tbed.13803</infon><infon key="pub-id_pmid">32810370</infon><infon key="section_type">REF</infon><infon key="source">Transbound. Emerg. Dis.</infon><infon key="type">ref</infon><infon key="volume">68</infon><infon key="year">2021</infon><offset>37978</offset><text>Detection of SARS-CoV-2 in pets living with COVID-19 owners diagnosed during the COVID-19 lockdown in Spain: A case of an asymptomatic cat with SARS-CoV-2 in Europe</text></passage><passage><infon key="fpage">3069</infon><infon key="lpage">3071</infon><infon key="name_0">surname:Garigliany;given-names:M.</infon><infon key="name_1">surname:Van Laere;given-names:A.S.</infon><infon key="name_2">surname:Clercx;given-names:C.</infon><infon key="name_3">surname:Giet;given-names:D.</infon><infon key="name_4">surname:Escriou;given-names:N.</infon><infon key="name_5">surname:Huon;given-names:C.</infon><infon key="name_6">surname:Van Der Werf;given-names:S.</infon><infon key="name_7">surname:Eloit;given-names:M.</infon><infon key="name_8">surname:Desmecht;given-names:D.</infon><infon key="pub-id_doi">10.3201/eid2612.202223</infon><infon key="pub-id_pmid">32788033</infon><infon key="section_type">REF</infon><infon key="source">Emerg. Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">26</infon><infon key="year">2020</infon><offset>38143</offset><text>SARS-CoV-2 Natural Transmission from Human to Cat, Belgium, March 2020</text></passage><passage><infon key="fpage">2013</infon><infon key="lpage">2019</infon><infon key="name_0">surname:Zhang;given-names:Q.</infon><infon key="name_1">surname:Zhang;given-names:H.</infon><infon key="name_2">surname:Gao;given-names:J.</infon><infon key="name_3">surname:Huang;given-names:K.</infon><infon key="name_4">surname:Yang;given-names:Y.</infon><infon key="name_5">surname:Hui;given-names:X.</infon><infon key="name_6">surname:He;given-names:X.</infon><infon key="name_7">surname:Li;given-names:C.</infon><infon key="name_8">surname:Gong;given-names:W.</infon><infon key="name_9">surname:Zhang;given-names:Y.</infon><infon key="pub-id_doi">10.1080/22221751.2020.1817796</infon><infon key="pub-id_pmid">32867625</infon><infon key="section_type">REF</infon><infon key="source">Emerg. Microbes Infect.</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2020</infon><offset>38214</offset><text>A serological survey of SARS-CoV-2 in cat in Wuhan</text></passage><passage><infon key="fpage">1597</infon><infon key="lpage">1609</infon><infon key="name_0">surname:Dileepan;given-names:M.</infon><infon key="name_1">surname:Di;given-names:D.</infon><infon key="name_2">surname:Huang;given-names:Q.</infon><infon key="name_3">surname:Ahmed;given-names:S.</infon><infon key="name_4">surname:Heinrich;given-names:D.</infon><infon key="name_5">surname:Ly;given-names:H.</infon><infon key="name_6">surname:Liang;given-names:Y.</infon><infon key="pub-id_doi">10.1080/21505594.2021.1936433</infon><infon key="pub-id_pmid">34125647</infon><infon key="section_type">REF</infon><infon key="source">Virulence</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2021</infon><offset>38265</offset><text>Seroprevalence of SARS-CoV-2 (COVID-19) exposure in pet cats and dogs in Minnesota, USA</text></passage><passage><infon key="elocation-id">772</infon><infon key="name_0">surname:Michelitsch;given-names:A.</infon><infon key="name_1">surname:Hoffmann;given-names:D.</infon><infon key="name_2">surname:Wernike;given-names:K.</infon><infon key="name_3">surname:Beer;given-names:M.</infon><infon key="pub-id_doi">10.3390/vaccines8040772</infon><infon key="section_type">REF</infon><infon key="source">Vaccines</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2020</infon><offset>38353</offset><text>Occurrence of Antibodies against SARS-CoV-2 in the Domestic Cat Population of Germany</text></passage><passage><infon key="elocation-id">1813</infon><infon key="name_0">surname:Goryoka;given-names:G.W.</infon><infon key="name_1">surname:Cossaboom;given-names:C.M.</infon><infon key="name_2">surname:Gharpure;given-names:R.</infon><infon key="name_3">surname:Dawson;given-names:P.</infon><infon key="name_4">surname:Tansey;given-names:C.</infon><infon key="name_5">surname:Rossow;given-names:J.</infon><infon key="name_6">surname:Mrotz;given-names:V.</infon><infon key="name_7">surname:Rooney;given-names:J.</infon><infon key="name_8">surname:Torchetti;given-names:M.</infon><infon key="name_9">surname:Loiacono;given-names:C.M.</infon><infon key="pub-id_doi">10.3390/v13091813</infon><infon key="pub-id_pmid">34578394</infon><infon key="section_type">REF</infon><infon key="source">Viruses</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2021</infon><offset>38439</offset><text>One Health Investigation of SARS-CoV-2 Infection and Seropositivity among Pets in Households with Confirmed Human COVID-19 Cases—Utah and Wisconsin, 2020</text></passage><passage><infon key="fpage">100192</infon><infon key="name_0">surname:Fritz;given-names:M.</infon><infon key="name_1">surname:Rosolen;given-names:B.</infon><infon key="name_2">surname:Krafft;given-names:E.</infon><infon key="name_3">surname:Becquart;given-names:P.</infon><infon key="name_4">surname:Elguero;given-names:E.</infon><infon key="name_5">surname:Vratskikh;given-names:O.</infon><infon key="name_6">surname:Denolly;given-names:S.</infon><infon key="name_7">surname:Boson;given-names:B.</infon><infon key="name_8">surname:Vanhomwegen;given-names:J.</infon><infon key="name_9">surname:Gouilh;given-names:M.A.</infon><infon key="pub-id_doi">10.1016/j.onehlt.2020.100192</infon><infon key="pub-id_pmid">33169106</infon><infon key="section_type">REF</infon><infon key="source">One Health</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2020</infon><offset>38595</offset><text>High prevalence of SARS-CoV-2 antibodies in pets from COVID-19+ households</text></passage><passage><infon key="fpage">376</infon><infon key="lpage">383</infon><infon key="name_0">surname:Neira;given-names:V.</infon><infon key="name_1">surname:Brito;given-names:B.</infon><infon key="name_2">surname:Agüero;given-names:B.</infon><infon key="name_3">surname:Berrios;given-names:F.</infon><infon key="name_4">surname:Valdés;given-names:V.</infon><infon key="name_5">surname:Gutierrez;given-names:A.</infon><infon key="name_6">surname:Ariyama;given-names:N.</infon><infon key="name_7">surname:Espinoza;given-names:P.</infon><infon key="name_8">surname:Retamal;given-names:P.</infon><infon key="name_9">surname:Holmes;given-names:E.C.</infon><infon key="pub-id_doi">10.1080/22221751.2020.1863132</infon><infon key="pub-id_pmid">33317424</infon><infon key="section_type">REF</infon><infon key="source">Emerg. Microbes Infect.</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2021</infon><offset>38670</offset><text>A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners</text></passage><passage><infon key="fpage">1606</infon><infon key="lpage">1616</infon><infon key="name_0">surname:Chaintoutis;given-names:S.C.</infon><infon key="name_1">surname:Siarkou;given-names:V.I.</infon><infon key="name_2">surname:Mylonakis;given-names:M.E.</infon><infon key="name_3">surname:Kazakos;given-names:G.M.</infon><infon key="name_4">surname:Skeva;given-names:P.</infon><infon key="name_5">surname:Bampali;given-names:M.</infon><infon key="name_6">surname:Dimitriou;given-names:M.</infon><infon key="name_7">surname:Dovrolis;given-names:N.</infon><infon key="name_8">surname:Polizopoulou;given-names:Z.S.</infon><infon key="name_9">surname:Karakasiliotis;given-names:I.</infon><infon key="pub-id_doi">10.1111/tbed.14132</infon><infon key="pub-id_pmid">33908152</infon><infon key="section_type">REF</infon><infon key="source">Transbound. Emerg. Dis.</infon><infon key="type">ref</infon><infon key="volume">69</infon><infon key="year">2022</infon><offset>38786</offset><text>Limited cross-species transmission and absence of mutations associated with SARS-CoV-2 adaptation in cats: A case study of infection in a small household setting</text></passage><passage><infon key="elocation-id">618</infon><infon key="name_0">surname:Spada;given-names:E.</infon><infon key="name_1">surname:Vitale;given-names:F.</infon><infon key="name_2">surname:Bruno;given-names:F.</infon><infon key="name_3">surname:Castelli;given-names:G.</infon><infon key="name_4">surname:Reale;given-names:S.</infon><infon key="name_5">surname:Perego;given-names:R.</infon><infon key="name_6">surname:Baggiani;given-names:L.</infon><infon key="name_7">surname:Proverbio;given-names:D.</infon><infon key="pub-id_doi">10.3390/v13040618</infon><infon key="pub-id_pmid">33916759</infon><infon key="section_type">REF</infon><infon key="source">Viruses</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2021</infon><offset>38948</offset><text>A pre- and during Pandemic Survey of Sars-Cov-2 Infection in Stray Colony and Shelter Cats from a High Endemic Area of Northern Italy</text></passage><passage><infon key="name_0">surname:Udom;given-names:K.</infon><infon key="name_1">surname:Jairak;given-names:W.</infon><infon key="name_2">surname:Chamsai;given-names:E.</infon><infon key="name_3">surname:Charoenkul;given-names:K.</infon><infon key="name_4">surname:Boonyapisitsopa;given-names:S.</infon><infon key="name_5">surname:Bunpapong;given-names:N.</infon><infon key="name_6">surname:Techakriengkrai;given-names:N.</infon><infon key="name_7">surname:Amonsin;given-names:A.</infon><infon key="pub-id_doi">10.1111/tbed.14208</infon><infon key="section_type">REF</infon><infon key="source">Transbound. Emerg. Dis.</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>39082</offset><text>Serological survey of antibodies against SARS-CoV-2 in dogs and cats, Thailand</text></passage><passage><infon key="comment">[Portugal Is Pet Friendly Country] Available online: https://www.gfk.com/pt/insights/press-release/portugal-e-um-pais-pet-friendly/</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>39161</offset><text>GfKTrack.2PETs Portugal é um País Pet-Friendly</text></passage><passage><infon key="fpage">115</infon><infon key="lpage">125</infon><infon key="name_0">surname:Alho;given-names:A.M.</infon><infon key="name_1">surname:Pontes;given-names:J.</infon><infon key="name_2">surname:Pomba;given-names:C.</infon><infon key="pub-id_doi">10.1080/10888705.2015.1117976</infon><infon key="pub-id_pmid">26756929</infon><infon key="section_type">REF</infon><infon key="source">J. Appl. Anim. Welf. Sci.</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2016</infon><offset>39210</offset><text>Guardians’ Knowledge and Husbandry Practices of Feline Environmental Enrichment</text></passage><passage><infon key="name_0">surname:Patterson;given-names:E.I.</infon><infon key="name_1">surname:Elia;given-names:G.</infon><infon key="name_2">surname:Grassi;given-names:A.</infon><infon key="name_3">surname:Giordano;given-names:A.</infon><infon key="name_4">surname:Desario;given-names:C.</infon><infon key="name_5">surname:Medardo;given-names:M.</infon><infon key="name_6">surname:Smith;given-names:S.L.</infon><infon key="name_7">surname:Anderson;given-names:E.R.</infon><infon key="name_8">surname:Prince;given-names:T.</infon><infon key="name_9">surname:Patterson;given-names:G.T.</infon><infon key="pub-id_doi">10.1038/s41467-020-20097-0</infon><infon key="section_type">REF</infon><infon key="source">bioRxiv.</infon><infon key="type">ref</infon><infon key="year">2020</infon><offset>39292</offset><text>Evidence of exposure to SARS-CoV-2 in cats and dogs from households in Italy</text></passage><passage><infon key="fpage">336</infon><infon key="lpage">342</infon><infon key="name_0">surname:Michael;given-names:H.T.</infon><infon key="name_1">surname:Waterhouse;given-names:T.</infon><infon key="name_2">surname:Estrada;given-names:M.</infon><infon key="name_3">surname:Seguin;given-names:M.A.</infon><infon key="pub-id_doi">10.1111/jsap.13300</infon><infon key="pub-id_pmid">33521974</infon><infon key="section_type">REF</infon><infon key="source">J. Small Anim. Pract.</infon><infon key="type">ref</infon><infon key="volume">62</infon><infon key="year">2021</infon><offset>39369</offset><text>Frequency of respiratory pathogens and SARS-CoV-2 in canine and feline samples submitted for respiratory testing in early 2020</text></passage><passage><infon key="elocation-id">1453</infon><infon key="name_0">surname:Klaus;given-names:J.</infon><infon key="name_1">surname:Zini;given-names:E.</infon><infon key="name_2">surname:Hartmann;given-names:K.</infon><infon key="name_3">surname:Egberink;given-names:H.</infon><infon key="name_4">surname:Kipar;given-names:A.</infon><infon key="name_5">surname:Bergmann;given-names:M.</infon><infon key="name_6">surname:Palizzotto;given-names:C.</infon><infon key="name_7">surname:Zhao;given-names:S.</infon><infon key="name_8">surname:Rossi;given-names:F.</infon><infon key="name_9">surname:Franco;given-names:V.</infon><infon key="pub-id_doi">10.3390/v13081453</infon><infon key="pub-id_pmid">34452319</infon><infon key="section_type">REF</infon><infon key="source">Viruses</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2021</infon><offset>39496</offset><text>SARS-CoV-2 Infection in Dogs and Cats from Southern Germany and Northern Italy during the First Wave of the COVID-19 Pandemic</text></passage><passage><infon key="elocation-id">345</infon><infon key="name_0">surname:Barroso;given-names:R.</infon><infon key="name_1">surname:Vieira-Pires;given-names:A.</infon><infon key="name_2">surname:Antunes;given-names:A.</infon><infon key="name_3">surname:Fidalgo-Carvalho;given-names:I.</infon><infon key="pub-id_doi">10.3390/microorganisms10020345</infon><infon key="pub-id_pmid">35208799</infon><infon key="section_type">REF</infon><infon key="source">Microorganisms</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2022</infon><offset>39622</offset><text>Susceptibility of Pets to SARS-CoV-2 Infection: Lessons from a Seroepidemiologic Survey of Cats and Dogs in Portugal</text></passage><passage><infon key="fpage">707368</infon><infon key="name_0">surname:Yilmaz;given-names:A.</infon><infon key="name_1">surname:Kayar;given-names:A.</infon><infon key="name_2">surname:Turan;given-names:N.</infon><infon key="name_3">surname:Iskefli;given-names:O.</infon><infon key="name_4">surname:Bayrakal;given-names:A.</infon><infon key="name_5">surname:Roman-Sosa;given-names:G.</infon><infon key="name_6">surname:Or;given-names:E.</infon><infon key="name_7">surname:Tali;given-names:H.E.</infon><infon key="name_8">surname:Kocazeybek;given-names:B.</infon><infon key="name_9">surname:Karaali;given-names:R.</infon><infon key="pub-id_doi">10.3389/fvets.2021.707368</infon><infon key="pub-id_pmid">34712718</infon><infon key="section_type">REF</infon><infon key="source">Front. Vet. Sci.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2021</infon><offset>39739</offset><text>Presence of Antibodies to SARS-CoV-2 in Domestic Cats in Istanbul, Turkey, Before and After COVID-19 Pandemic</text></passage><passage><infon key="fpage">393</infon><infon key="lpage">405</infon><infon key="name_0">surname:McNamara;given-names:T.</infon><infon key="name_1">surname:Richt;given-names:J.A.</infon><infon key="name_2">surname:Glickman;given-names:L.</infon><infon key="pub-id_doi">10.1089/vbz.2020.2650</infon><infon key="pub-id_pmid">32374208</infon><infon key="section_type">REF</infon><infon key="source">Vector Borne Zoonotic Dis.</infon><infon key="type">ref</infon><infon key="volume">20</infon><infon key="year">2020</infon><offset>39849</offset><text>A Critical Needs Assessment for Research in Companion Animals and Livestock Following the Pandemic of COVID-19 in Humans</text></passage><passage><infon key="fpage">3115</infon><infon key="lpage">3118</infon><infon key="name_0">surname:Schulz;given-names:C.</infon><infon key="name_1">surname:Martina;given-names:B.</infon><infon key="name_2">surname:Mirolo;given-names:M.</infon><infon key="name_3">surname:Müller;given-names:E.</infon><infon key="name_4">surname:Klein;given-names:R.</infon><infon key="name_5">surname:Volk;given-names:H.</infon><infon key="name_6">surname:Egberink;given-names:H.</infon><infon key="name_7">surname:Gonzalez-Hernandez;given-names:M.</infon><infon key="name_8">surname:Kaiser;given-names:F.</infon><infon key="name_9">surname:von Köckritz-Blickwede;given-names:M.</infon><infon key="pub-id_doi">10.3201/eid2712.211252</infon><infon key="pub-id_pmid">34695368</infon><infon key="section_type">REF</infon><infon key="source">Emerg. Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2021</infon><offset>39970</offset><text>SARS-CoV-2–Specific Antibodies in Domestic Cats during First COVID-19 Wave, Europe</text></passage><passage><infon key="name_0">surname:Decaro;given-names:N.</infon><infon key="name_1">surname:Grassi;given-names:A.</infon><infon key="name_2">surname:Lorusso;given-names:E.</infon><infon key="name_3">surname:Patterson;given-names:E.I.</infon><infon key="name_4">surname:Lorusso;given-names:A.</infon><infon key="name_5">surname:Desario;given-names:C.</infon><infon key="name_6">surname:Anderson;given-names:E.R.</infon><infon key="name_7">surname:Vasinioti;given-names:V.</infon><infon key="name_8">surname:Wastika;given-names:C.E.</infon><infon key="name_9">surname:Hughes;given-names:G.L.</infon><infon key="pub-id_doi">10.1111/tbed.14308</infon><infon key="section_type">REF</infon><infon key="source">Transbound. Emerg. Dis.</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>40055</offset><text>Long-term persistence of neutralizing SARS-CoV-2 antibodies in pets</text></passage><passage><infon key="fpage">85</infon><infon key="lpage">91</infon><infon key="name_0">surname:Staines;given-names:H.M.</infon><infon key="name_1">surname:Kirwan;given-names:D.E.</infon><infon key="name_2">surname:Clark;given-names:D.J.</infon><infon key="name_3">surname:Adams;given-names:E.R.</infon><infon key="name_4">surname:Augustin;given-names:Y.</infon><infon key="name_5">surname:Byrne;given-names:R.L.</infon><infon key="name_6">surname:Cocozza;given-names:M.</infon><infon key="name_7">surname:Cubas-Atienzar;given-names:A.I.</infon><infon key="name_8">surname:Cuevas;given-names:L.E.</infon><infon key="name_9">surname:Cusinato;given-names:M.</infon><infon key="pub-id_doi">10.3201/eid2701.203074</infon><infon key="pub-id_pmid">33256890</infon><infon key="section_type">REF</infon><infon key="source">Emerg. Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2021</infon><offset>40123</offset><text>IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection</text></passage><passage><infon key="fpage">113</infon><infon key="lpage">121</infon><infon key="name_0">surname:Gallais;given-names:F.</infon><infon key="name_1">surname:Velay;given-names:A.</infon><infon key="name_2">surname:Nazon;given-names:C.</infon><infon key="name_3">surname:Wendling;given-names:M.-J.</infon><infon key="name_4">surname:Partisani;given-names:M.</infon><infon key="name_5">surname:Sibilia;given-names:J.</infon><infon key="name_6">surname:Candon;given-names:S.</infon><infon key="name_7">surname:Fafi-Kremer;given-names:S.</infon><infon key="pub-id_doi">10.3201/eid2701.203611</infon><infon key="section_type">REF</infon><infon key="source">Emerg. Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2021</infon><offset>40223</offset><text>Intrafamilial Exposure to SARS-CoV-2 Associated with Cellular Immune Response without Seroconversion, France</text></passage><passage><infon key="fpage">e01828-20</infon><infon key="name_0">surname:Fenwick;given-names:C.</infon><infon key="name_1">surname:Croxatto;given-names:A.</infon><infon key="name_2">surname:Coste;given-names:A.T.</infon><infon key="name_3">surname:Pojer;given-names:F.</infon><infon key="name_4">surname:André;given-names:C.</infon><infon key="name_5">surname:Pellaton;given-names:C.</infon><infon key="name_6">surname:Farina;given-names:A.</infon><infon key="name_7">surname:Campos;given-names:J.</infon><infon key="name_8">surname:Hacker;given-names:D.</infon><infon key="name_9">surname:Lau;given-names:K.</infon><infon key="pub-id_doi">10.1128/JVI.01828-20</infon><infon key="pub-id_pmid">33144321</infon><infon key="section_type">REF</infon><infon key="source">J. Virol.</infon><infon key="type">ref</infon><infon key="volume">95</infon><infon key="year">2021</infon><offset>40332</offset><text>Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies</text></passage><passage><infon key="elocation-id">e0250853</infon><infon key="name_0">surname:Calvet;given-names:G.A.</infon><infon key="name_1">surname:Pereira;given-names:S.A.</infon><infon key="name_2">surname:Ogrzewalska;given-names:M.</infon><infon key="name_3">surname:Pauvolid-Corrêa;given-names:A.</infon><infon key="name_4">surname:Resende;given-names:P.C.</infon><infon key="name_5">surname:Tassinari;given-names:W.D.S.</infon><infon key="name_6">surname:Costa;given-names:A.D.P.</infon><infon key="name_7">surname:Keidel;given-names:L.O.</infon><infon key="name_8">surname:da Rocha;given-names:A.S.B.</infon><infon key="name_9">surname:da Silva;given-names:M.F.B.</infon><infon key="pub-id_doi">10.1371/journal.pone.0250853</infon><infon key="pub-id_pmid">33909706</infon><infon key="section_type">REF</infon><infon key="source">PLoS ONE</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2021</infon><offset>40478</offset><text>Investigation of SARS-CoV-2 infection in dogs and cats of humans diagnosed with COVID-19 in Rio de Janeiro, Brazil</text></passage><passage><infon key="fpage">1362</infon><infon key="lpage">1370</infon><infon key="name_0">surname:Zhao;given-names:S.</infon><infon key="name_1">surname:Schuurman;given-names:N.</infon><infon key="name_2">surname:Li;given-names:W.</infon><infon key="name_3">surname:Wang;given-names:C.</infon><infon key="name_4">surname:Smit;given-names:L.A.</infon><infon key="name_5">surname:Broens;given-names:E.M.</infon><infon key="name_6">surname:Wagenaar;given-names:J.A.</infon><infon key="name_7">surname:van Kuppeveld;given-names:F.J.</infon><infon key="name_8">surname:Bosch;given-names:B.-J.</infon><infon key="name_9">surname:Egberink;given-names:H.</infon><infon key="pub-id_doi">10.3201/eid2705.204055</infon><infon key="pub-id_pmid">33900184</infon><infon key="section_type">REF</infon><infon key="source">Emerg. Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2021</infon><offset>40593</offset><text>Serologic Screening of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Cats and Dogs during First Coronavirus Disease Wave, the Netherlands</text></passage><passage><infon key="fpage">1056</infon><infon key="lpage">1064</infon><infon key="name_0">surname:Villanueva-Saz;given-names:S.</infon><infon key="name_1">surname:Giner;given-names:J.</infon><infon key="name_2">surname:Tobajas;given-names:A.P.</infon><infon key="name_3">surname:Pérez;given-names:M.D.</infon><infon key="name_4">surname:González-Ramírez;given-names:A.M.</infon><infon key="name_5">surname:Macías-León;given-names:J.</infon><infon key="name_6">surname:González;given-names:A.</infon><infon key="name_7">surname:Verde;given-names:M.</infon><infon key="name_8">surname:Yzuel;given-names:A.</infon><infon key="name_9">surname:Hurtado-Guerrero;given-names:R.</infon><infon key="pub-id_doi">10.1111/tbed.14062</infon><infon key="pub-id_pmid">33686768</infon><infon key="section_type">REF</infon><infon key="source">Transbound. Emerg. Dis.</infon><infon key="type">ref</infon><infon key="volume">69</infon><infon key="year">2022</infon><offset>40746</offset><text>Serological evidence of SARS-CoV-2 and co-infections in stray cats in Spain</text></passage><passage><infon key="elocation-id">e0248578</infon><infon key="name_0">surname:Dias;given-names:H.G.</infon><infon key="name_1">surname:Resck;given-names:M.E.B.</infon><infon key="name_2">surname:Caldas;given-names:G.C.</infon><infon key="name_3">surname:Resck;given-names:A.F.</infon><infon key="name_4">surname:da Silva;given-names:N.V.</infon><infon key="name_5">surname:dos Santos;given-names:A.M.V.</infon><infon key="name_6">surname:Sousa;given-names:T.d.C.</infon><infon key="name_7">surname:Ogrzewalska;given-names:M.H.</infon><infon key="name_8">surname:Siqueira;given-names:M.M.</infon><infon key="name_9">surname:Pauvolid-Corrêa;given-names:A.</infon><infon key="pub-id_doi">10.1371/journal.pone.0248578</infon><infon key="pub-id_pmid">33765012</infon><infon key="section_type">REF</infon><infon key="source">PLoS ONE</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2021</infon><offset>40822</offset><text>Neutralizing antibodies for SARS-CoV-2 in stray animals from Rio de Janeiro, Brazil</text></passage><passage><infon key="fpage">e03647-20</infon><infon key="name_0">surname:Ng;given-names:W.H.</infon><infon key="name_1">surname:Tipih;given-names:T.</infon><infon key="name_2">surname:Makoah;given-names:N.A.</infon><infon key="name_3">surname:Vermeulen;given-names:J.-G.</infon><infon key="name_4">surname:Goedhals;given-names:D.</infon><infon key="name_5">surname:Sempa;given-names:J.B.</infon><infon key="name_6">surname:Burt;given-names:F.J.</infon><infon key="name_7">surname:Taylor;given-names:A.</infon><infon key="name_8">surname:Mahalingam;given-names:S.</infon><infon key="pub-id_doi">10.1128/mBio.03647-20</infon><infon key="pub-id_pmid">33563817</infon><infon key="section_type">REF</infon><infon key="source">mBio</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2021</infon><offset>40906</offset><text>Comorbidities in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis</text></passage><passage><infon key="fpage">91</infon><infon key="lpage">95</infon><infon key="name_0">surname:Yang;given-names:J.</infon><infon key="name_1">surname:Zheng;given-names:Y.</infon><infon key="name_2">surname:Gou;given-names:X.</infon><infon key="name_3">surname:Pu;given-names:K.</infon><infon key="name_4">surname:Chen;given-names:Z.</infon><infon key="name_5">surname:Guo;given-names:Q.</infon><infon key="name_6">surname:Ji;given-names:R.</infon><infon key="name_7">surname:Wang;given-names:H.</infon><infon key="name_8">surname:Wang;given-names:Y.</infon><infon key="name_9">surname:Zhou;given-names:Y.</infon><infon key="pub-id_doi">10.1016/j.ijid.2020.03.017</infon><infon key="pub-id_pmid">32173574</infon><infon key="section_type">REF</infon><infon key="source">Int. J. Infect. Dis.</infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">2020</infon><offset>40982</offset><text>Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: A systematic review and meta-analysis</text></passage><passage><infon key="fpage">1715</infon><infon key="lpage">1725</infon><infon key="name_0">surname:Banerjee;given-names:A.</infon><infon key="name_1">surname:Pasea;given-names:L.</infon><infon key="name_2">surname:Harris;given-names:S.</infon><infon key="name_3">surname:Gonzalez-Izquierdo;given-names:A.</infon><infon key="name_4">surname:Torralbo;given-names:A.</infon><infon key="name_5">surname:Shallcross;given-names:L.</infon><infon key="name_6">surname:Noursadeghi;given-names:M.</infon><infon key="name_7">surname:Pillay;given-names:D.</infon><infon key="name_8">surname:Sebire;given-names:N.</infon><infon key="name_9">surname:Holmes;given-names:C.</infon><infon key="pub-id_doi">10.1016/S0140-6736(20)30854-0</infon><infon key="pub-id_pmid">32405103</infon><infon key="section_type">REF</infon><infon key="source">Lancet</infon><infon key="type">ref</infon><infon key="volume">395</infon><infon key="year">2020</infon><offset>41102</offset><text>Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: A population-based cohort study</text></passage><passage><infon key="elocation-id">527</infon><infon key="name_0">surname:Klaus;given-names:J.</infon><infon key="name_1">surname:Palizzotto;given-names:C.</infon><infon key="name_2">surname:Zini;given-names:E.</infon><infon key="name_3">surname:Meli;given-names:M.</infon><infon key="name_4">surname:Leo;given-names:C.</infon><infon key="name_5">surname:Egberink;given-names:H.</infon><infon key="name_6">surname:Zhao;given-names:S.</infon><infon key="name_7">surname:Hofmann-Lehmann;given-names:R.</infon><infon key="pub-id_doi">10.3390/v13030527</infon><infon key="pub-id_pmid">33806922</infon><infon key="section_type">REF</infon><infon key="source">Viruses</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2021</infon><offset>41251</offset><text>SARS-CoV-2 Infection and Antibody Response in a Symptomatic Cat from Italy with Intestinal B-Cell Lymphoma</text></passage><passage><infon key="elocation-id">1510</infon><infon key="name_0">surname:Carvallo;given-names:F.R.</infon><infon key="name_1">surname:Martins;given-names:M.</infon><infon key="name_2">surname:Joshi;given-names:L.</infon><infon key="name_3">surname:Caserta;given-names:L.</infon><infon key="name_4">surname:Mitchell;given-names:P.</infon><infon key="name_5">surname:Cecere;given-names:T.</infon><infon key="name_6">surname:Hancock;given-names:S.</infon><infon key="name_7">surname:Goodrich;given-names:E.</infon><infon key="name_8">surname:Murphy;given-names:J.</infon><infon key="name_9">surname:Diel;given-names:D.</infon><infon key="pub-id_doi">10.3390/v13081510</infon><infon key="pub-id_pmid">34452375</infon><infon key="section_type">REF</infon><infon key="source">Viruses</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2021</infon><offset>41358</offset><text>Severe SARS-CoV-2 Infection in a Cat with Hypertrophic Cardiomyopathy</text></passage><passage><infon key="fpage">899</infon><infon key="lpage">906</infon><infon key="name_0">surname:Tewari;given-names:D.</infon><infon key="name_1">surname:Boger;given-names:L.</infon><infon key="name_2">surname:Brady;given-names:S.</infon><infon key="name_3">surname:Livengood;given-names:J.</infon><infon key="name_4">surname:Killian;given-names:M.L.</infon><infon key="name_5">surname:Nair;given-names:M.S.</infon><infon key="name_6">surname:Thirumalapura;given-names:N.</infon><infon key="name_7">surname:Kuchipudi;given-names:S.V.</infon><infon key="name_8">surname:Zellers;given-names:C.</infon><infon key="name_9">surname:Schroder;given-names:B.</infon><infon key="pub-id_doi">10.1002/vms3.695</infon><infon key="pub-id_pmid">34910368</infon><infon key="section_type">REF</infon><infon key="source">Vet. Med. Sci.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2022</infon><offset>41428</offset><text>Transmission of SARS-CoV-2 from humans to a 16-year-old domestic cat with comorbidities in Pennsylvania, USA</text></passage><passage><infon key="fpage">103492</infon><infon key="name_0">surname:Mattos-Silva;given-names:P.</infon><infon key="name_1">surname:Felix;given-names:N.S.</infon><infon key="name_2">surname:Silva;given-names:P.L.</infon><infon key="name_3">surname:Robba;given-names:C.</infon><infon key="name_4">surname:Battaglini;given-names:D.</infon><infon key="name_5">surname:Pelosi;given-names:P.</infon><infon key="name_6">surname:Rocco;given-names:P.R.M.</infon><infon key="name_7">surname:Cruz;given-names:F.F.</infon><infon key="pub-id_doi">10.1016/j.resp.2020.103492</infon><infon key="pub-id_pmid">32659271</infon><infon key="section_type">REF</infon><infon key="source">Respir. Physiol. Neurobiol.</infon><infon key="type">ref</infon><infon key="volume">280</infon><infon key="year">2020</infon><offset>41537</offset><text>Pros and cons of corticosteroid therapy for COVID-19 patients</text></passage><passage><infon key="fpage">757</infon><infon key="lpage">773</infon><infon key="name_0">surname:Tao;given-names:K.</infon><infon key="name_1">surname:Tzou;given-names:P.</infon><infon key="name_2">surname:Nouhin;given-names:J.</infon><infon key="name_3">surname:Gupta;given-names:R.K.</infon><infon key="name_4">surname:de Oliveira;given-names:T.</infon><infon key="name_5">surname:Kosakovsky Pond;given-names:S.L.</infon><infon key="name_6">surname:Fera;given-names:D.</infon><infon key="name_7">surname:Shafer;given-names:R.W.</infon><infon key="pub-id_doi">10.1038/s41576-021-00408-x</infon><infon key="pub-id_pmid">34535792</infon><infon key="section_type">REF</infon><infon key="source">Nat. Rev. Genet.</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2021</infon><offset>41599</offset><text>The biological and clinical significance of emerging SARS-CoV-2 variants</text></passage><passage><infon key="fpage">809244</infon><infon key="name_0">surname:Mistry;given-names:P.</infon><infon key="name_1">surname:Barmania;given-names:F.</infon><infon key="name_2">surname:Mellet;given-names:J.</infon><infon key="name_3">surname:Peta;given-names:K.</infon><infon key="name_4">surname:Strydom;given-names:A.</infon><infon key="name_5">surname:Viljoen;given-names:I.M.</infon><infon key="name_6">surname:James;given-names:W.</infon><infon key="name_7">surname:Gordon;given-names:S.</infon><infon key="name_8">surname:Pepper;given-names:M.S.</infon><infon key="pub-id_doi">10.3389/fimmu.2021.809244</infon><infon key="pub-id_pmid">35046961</infon><infon key="section_type">REF</infon><infon key="source">Front. Immunol.</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2022</infon><offset>41672</offset><text>SARS-CoV-2 Variants, Vaccines, and Host Immunity</text></passage><passage><infon key="name_0">surname:Jairak;given-names:W.</infon><infon key="name_1">surname:Charoenkul;given-names:K.</infon><infon key="name_2">surname:Chamsai;given-names:E.</infon><infon key="name_3">surname:Udom;given-names:K.</infon><infon key="name_4">surname:Chaiyawong;given-names:S.</infon><infon key="name_5">surname:Bunpapong;given-names:N.</infon><infon key="name_6">surname:Boonyapisitsopa;given-names:S.</infon><infon key="name_7">surname:Tantilertcharoen;given-names:R.</infon><infon key="name_8">surname:Techakriengkrai;given-names:N.</infon><infon key="name_9">surname:Surachetpong;given-names:S.</infon><infon key="pub-id_doi">10.1111/tbed.14383</infon><infon key="pub-id_pmid">34739748</infon><infon key="section_type">REF</infon><infon key="source">Transbound. Emerg. Dis.</infon><infon key="type">ref</infon><infon key="year">2021</infon><offset>41721</offset><text>First cases of SARS-CoV-2 infection in dogs and cats in Thailand</text></passage><passage><infon key="fpage">1656</infon><infon key="lpage">1658</infon><infon key="name_0">surname:Hamer;given-names:S.A.</infon><infon key="name_1">surname:Ghai;given-names:R.R.</infon><infon key="name_2">surname:Zecca;given-names:I.B.</infon><infon key="name_3">surname:Auckland;given-names:L.D.</infon><infon key="name_4">surname:Roundy;given-names:C.M.</infon><infon key="name_5">surname:Davila;given-names:E.</infon><infon key="name_6">surname:Busselman;given-names:R.E.</infon><infon key="name_7">surname:Tang;given-names:W.</infon><infon key="name_8">surname:Pauvolid-Corrêa;given-names:A.</infon><infon key="name_9">surname:Killian;given-names:M.L.</infon><infon key="pub-id_doi">10.1111/tbed.14122</infon><infon key="pub-id_pmid">33955193</infon><infon key="section_type">REF</infon><infon key="source">Transbound. Emerg. Dis.</infon><infon key="type">ref</infon><infon key="volume">69</infon><infon key="year">2022</infon><offset>41786</offset><text>SARS-CoV-2 B.1.1.7 variant of concern detected in a pet dog and cat after exposure to a person with COVID-19, USA</text></passage><passage><infon key="fpage">779341</infon><infon key="name_0">surname:Miró;given-names:G.</infon><infon key="name_1">surname:Regidor-Cerrillo;given-names:J.</infon><infon key="name_2">surname:Checa;given-names:R.</infon><infon key="name_3">surname:Diezma-Díaz;given-names:C.</infon><infon key="name_4">surname:Montoya;given-names:A.</infon><infon key="name_5">surname:García-Cantalejo;given-names:J.</infon><infon key="name_6">surname:Botías;given-names:P.</infon><infon key="name_7">surname:Arroyo;given-names:J.</infon><infon key="name_8">surname:Ortega-Mora;given-names:L.-M.</infon><infon key="pub-id_doi">10.3389/fvets.2021.779341</infon><infon key="pub-id_pmid">34901253</infon><infon key="section_type">REF</infon><infon key="source">Front. Vet. Sci.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2021</infon><offset>41900</offset><text>SARS-CoV-2 Infection in One Cat and Three Dogs Living in COVID-19-Positive Households in Madrid, Spain</text></passage><passage><infon key="fpage">e944</infon><infon key="name_0">surname:Ferasin;given-names:L.</infon><infon key="name_1">surname:Fritz;given-names:M.</infon><infon key="name_2">surname:Ferasin;given-names:H.</infon><infon key="name_3">surname:Becquart;given-names:P.</infon><infon key="name_4">surname:Corbet;given-names:S.</infon><infon key="name_5">surname:Gouilh;given-names:M.A.</infon><infon key="name_6">surname:Legros;given-names:V.</infon><infon key="name_7">surname:Leroy;given-names:E.M.</infon><infon key="pub-id_doi">10.1002/vetr.944</infon><infon key="pub-id_pmid">34738231</infon><infon key="section_type">REF</infon><infon key="source">Vet. Rec.</infon><infon key="type">ref</infon><infon key="volume">189</infon><infon key="year">2021</infon><offset>42003</offset><text>Infection with SARS-CoV-2 variant B.1.1.7 detected in a group of dogs and cats with suspected myocarditis</text></passage><passage><infon key="fpage">93</infon><infon key="name_0">surname:Carneiro;given-names:R.L.</infon><infon key="name_1">surname:Farias;given-names:J.P.</infon><infon key="name_2">surname:Pinheiro;given-names:J.R.</infon><infon key="name_3">surname:Farias;given-names:J.</infon><infon key="name_4">surname:Vielmo;given-names:A.C.</infon><infon key="name_5">surname:Birbrair;given-names:A.</infon><infon key="name_6">surname:Belmok;given-names:A.</infon><infon key="name_7">surname:Melo;given-names:F.L.</infon><infon key="name_8">surname:Ribeiro;given-names:B.M.</infon><infon key="name_9">surname:Chaves;given-names:G.</infon><infon key="pub-id_doi">10.1186/s12985-022-01816-z</infon><infon key="pub-id_pmid">35619142</infon><infon key="section_type">REF</infon><infon key="source">Virol. J.</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2022</infon><offset>42109</offset><text>First description of a multisystemic and lethal SARS-CoV-2 variant of concern P.1 (Gamma) infection in a FeLV-positive cat</text></passage><passage><infon key="fpage">945</infon><infon key="lpage">946</infon><infon key="name_0">surname:Kang;given-names:K.</infon><infon key="name_1">surname:Chen;given-names:Q.</infon><infon key="name_2">surname:Gao;given-names:Y.</infon><infon key="name_3">surname:Yu;given-names:K.</infon><infon key="pub-id_doi">10.1002/vms3.715</infon><infon key="pub-id_pmid">34958181</infon><infon key="section_type">REF</infon><infon key="source">Vet. Med. Sci.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2022</infon><offset>42232</offset><text>Detection of SARS-CoV-2 B.1.617.2 (Delta) variant in three cats owned by a confirmed COVID-19 patient in Harbin, China</text></passage><passage><infon key="elocation-id">421</infon><infon key="name_0">surname:Lenz;given-names:O.C.</infon><infon key="name_1">surname:Marques;given-names:A.D.</infon><infon key="name_2">surname:Kelly;given-names:B.J.</infon><infon key="name_3">surname:Rodino;given-names:K.G.</infon><infon key="name_4">surname:Cole;given-names:S.D.</infon><infon key="name_5">surname:Perera;given-names:R.A.P.M.</infon><infon key="name_6">surname:Weiss;given-names:S.R.</infon><infon key="name_7">surname:Bushman;given-names:F.D.</infon><infon key="name_8">surname:Lennon;given-names:E.M.</infon><infon key="pub-id_doi">10.3390/v14020421</infon><infon key="pub-id_pmid">35216014</infon><infon key="section_type">REF</infon><infon key="source">Viruses</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2022</infon><offset>42351</offset><text>SARS-CoV-2 Delta Variant (AY.3) in the Feces of a Domestic Cat</text></passage><passage><infon key="file">vetsci-09-00363-g001.jpg</infon><infon key="id">vetsci-09-00363-f001</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>42414</offset><text>Geographical distribution of sampled cats and cumulative human COVID-19 cases. (a) The number of sampled cats by district is shown by the color gradient, as indicated in the legend. The district of residence of SARS-CoV-2-positive cats is marked with a circle. (b) The number of cumulative human COVID-19 cases at the end of October 2021 by district is shown by color gradient, as indicated in the legend.</text></passage><passage><infon key="file">vetsci-09-00363-g002.jpg</infon><infon key="id">vetsci-09-00363-f002</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>42820</offset><text>SARS-CoV-2 seropositivity among cats from COVID-19-positive and -negative households.</text></passage><passage><infon key="file">vetsci-09-00363-g003.jpg</infon><infon key="id">vetsci-09-00363-f003</infon><infon key="section_type">FIG</infon><infon key="type">fig_caption</infon><offset>42906</offset><text>anti-SARS-CoV-2 antibody screening results by ELISA. S/P% of negative samples (NS) and positive samples (PS) are represented by bar graph showing mean + standard deviation. The dotted line represents S/P% cutoff.</text></passage><passage><infon key="file">vetsci-09-00363-t001.xml</infon><infon key="id">vetsci-09-00363-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>43119</offset><text>Characterization of household, including demographics and household composition (n = 94; otherwise, n value is presented).</text></passage><passage><infon key="file">vetsci-09-00363-t001.xml</infon><infon key="id">vetsci-09-00363-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Category&lt;/th&gt;&lt;th colspan=&quot;2&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot;&gt;Characteristics&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Percentage (%)&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td rowspan=&quot;5&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; colspan=&quot;1&quot;&gt;Demographics&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sex&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Female&lt;break/&gt;Male&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;86.2&lt;break/&gt;13.8&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Age (years)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;18–30&lt;break/&gt;30–50&lt;break/&gt;50–70&lt;break/&gt;&amp;gt;70&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;21.3&lt;break/&gt;43.6&lt;break/&gt;29.8&lt;break/&gt;5.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Educational qualification&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Basic education&lt;break/&gt;High school&lt;break/&gt;Degree&lt;break/&gt;Master’s&lt;break/&gt;Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;20.2&lt;break/&gt;26.6&lt;break/&gt;28.7&lt;break/&gt;17.0&lt;break/&gt;7.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Professional activity&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Employed&lt;break/&gt;Retired&lt;break/&gt;Unemployed&lt;break/&gt;Student&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;73.4&lt;break/&gt;14.9&lt;break/&gt;7.4&lt;break/&gt;4.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;District of residence&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Porto&lt;break/&gt;Évora&lt;break/&gt;Braga&lt;break/&gt;Viseu&lt;break/&gt;Aveiro&lt;break/&gt;Beja&lt;break/&gt;Setúbal&lt;break/&gt;Portalegre&lt;break/&gt;Viana do Castelo&lt;break/&gt;Faro&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;50&lt;break/&gt;13.8&lt;break/&gt;12.8&lt;break/&gt;5.3&lt;break/&gt;5.3&lt;break/&gt;4.2&lt;break/&gt;3.2&lt;break/&gt;3.2&lt;break/&gt;1.1&lt;break/&gt;1.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;2&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; colspan=&quot;1&quot;&gt;Household&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Human members&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1&lt;break/&gt;2&lt;break/&gt;3&lt;break/&gt;4&lt;break/&gt;Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;14.9&lt;break/&gt;38.3&lt;break/&gt;21.3&lt;break/&gt;21.3&lt;break/&gt;4.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pets (&lt;italic toggle=&quot;yes&quot;&gt;n&lt;/italic&gt; = 79)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dog&lt;break/&gt;Cat&lt;break/&gt;Bird&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;58.2&lt;break/&gt;38.0&lt;break/&gt;3.8&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>43242</offset><text>Category	Characteristics	Percentage (%)	 	Demographics	Sex	FemaleMale	86.213.8	 	Age (years)	18–3030–5050–70&gt;70	21.343.629.85.3	 	Educational qualification	Basic educationHigh schoolDegreeMaster’sOther	20.226.628.717.07.5	 	Professional activity	EmployedRetiredUnemployedStudent	73.414.97.44.3	 	District of residence	PortoÉvoraBragaViseuAveiroBejaSetúbalPortalegreViana do CasteloFaro	5013.812.85.35.34.23.23.21.11.1	 	Household	Human members	1234Other	14.938.321.321.34.2	 	Pets (n = 79)	DogCatBird	58.238.03.8	 	</text></passage><passage><infon key="file">vetsci-09-00363-t002.xml</infon><infon key="id">vetsci-09-00363-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>43768</offset><text>Characterization of sampled cats. n = 176; otherwise, n value is presented.</text></passage><passage><infon key="file">vetsci-09-00363-t002.xml</infon><infon key="id">vetsci-09-00363-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Category&lt;/th&gt;&lt;th colspan=&quot;2&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot;&gt;Characteristics&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Percentage (%)&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td rowspan=&quot;4&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; colspan=&quot;1&quot;&gt;Signalment&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sex&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Female&lt;break/&gt;Male&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;52.8&lt;break/&gt;47.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Reproductive status&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fertile&lt;break/&gt;Non-fertile&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;6.8&lt;break/&gt;93.2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Age (years)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1–5&lt;break/&gt;5–10&lt;break/&gt;&amp;gt;10&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;45.5&lt;break/&gt;39.2&lt;break/&gt;15.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Breed&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;European shorthair&lt;break/&gt;Siamese&lt;break/&gt;Persian&lt;break/&gt;Norwegian Forest cat&lt;break/&gt;Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;84.7&lt;break/&gt;5.7&lt;break/&gt;4.5&lt;break/&gt;0.6&lt;break/&gt;4.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;3&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; colspan=&quot;1&quot;&gt;Environment&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Lifestyle&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Indoor&lt;break/&gt;Indoor/outdoor&lt;break/&gt;Outdoor&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;77.8&lt;break/&gt;20.5&lt;break/&gt;1.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Other animals&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes&lt;break/&gt;No&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;91.5&lt;break/&gt;8.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Co-habitant pets (&lt;italic toggle=&quot;yes&quot;&gt;n&lt;/italic&gt; = 161)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dog, cat&lt;break/&gt;Cat&lt;break/&gt;Dog&lt;break/&gt;Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;48.4&lt;break/&gt;30.4&lt;break/&gt;9.3&lt;break/&gt;11.9&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;7&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; colspan=&quot;1&quot;&gt;Clinical status&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Annual vaccination&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes&lt;break/&gt;No&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;78.4&lt;break/&gt;21.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Deworming&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes, every 3 months&lt;break/&gt;Yes, every 6 months&lt;break/&gt;Yes, annually&lt;break/&gt;Occasionally&lt;break/&gt;No&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;68.8&lt;break/&gt;15.9&lt;break/&gt;8.5&lt;break/&gt;4.5&lt;break/&gt;2.3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Chronic disease&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;No&lt;break/&gt;Yes&lt;break/&gt;Don’t know&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;80.1&lt;break/&gt;12.5&lt;break/&gt;7.4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Type of chronic disease (&lt;italic toggle=&quot;yes&quot;&gt;n&lt;/italic&gt; = 22)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Kidney/liver disease&lt;break/&gt;Retroviral infection&lt;break/&gt;Heart disease&lt;break/&gt;Gingivostomatitis&lt;break/&gt;Hypothyroidism&lt;break/&gt;Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;22.7&lt;break/&gt;22.7&lt;break/&gt;18.2&lt;break/&gt;9.1&lt;break/&gt;4.6&lt;break/&gt;22.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Medication (&lt;italic toggle=&quot;yes&quot;&gt;n&lt;/italic&gt; = 9)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Food supplements (oral hygiene, feline idiopathic cystitis, behavior, immunomodulators)&lt;break/&gt;Non-steroidal anti-inflammatory drugs&lt;break/&gt;Steroidal anti-inflammatory drugs&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;66.7&lt;break/&gt;22.2&lt;break/&gt;11.1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Clinical signs or behavior changes during pandemic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;No&lt;break/&gt;Yes&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;82.4&lt;break/&gt;17.6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Type of clinical signs or behavior changes during pandemic (&lt;italic toggle=&quot;yes&quot;&gt;n&lt;/italic&gt; = 31)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Behavioral changes&lt;break/&gt;Weight loss&lt;break/&gt;Respiratory clinical signs&lt;break/&gt;Appetite loss&lt;break/&gt;Digestive clinical signs&lt;break/&gt;Conjunctivitis&lt;break/&gt;Fever&lt;break/&gt;Skin problems&lt;break/&gt;Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;67.7&lt;break/&gt;9.7&lt;break/&gt;9.7&lt;break/&gt;6.5&lt;break/&gt;6.6&lt;break/&gt;6.5&lt;break/&gt;3.2&lt;break/&gt;3.2&lt;break/&gt;6.5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;3&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; colspan=&quot;1&quot;&gt;Interaction with humans&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Before pandemic, type of interaction&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Playing, petting, and cuddling&lt;break/&gt;Resting on the lap&lt;break/&gt;Sharing the bed&lt;break/&gt;Sharing the sofa&lt;break/&gt;Other&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;96.0&lt;break/&gt;72.2&lt;break/&gt;65.9&lt;break/&gt;64.8&lt;break/&gt;13.7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Before pandemic, frequency of interaction&lt;break/&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;All day&lt;break/&gt;Part of the day&lt;break/&gt;Occasionally&lt;break/&gt;Did not interact&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;48.3&lt;break/&gt;46.0&lt;break/&gt;6.25&lt;break/&gt;0.57&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;After household human COVID-19 diagnoses (&lt;italic toggle=&quot;yes&quot;&gt;n&lt;/italic&gt; = 36)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;As usual&lt;break/&gt;Reduced interaction&lt;break/&gt;Did not interact&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;86.1&lt;break/&gt;11.1&lt;break/&gt;2.8&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>43844</offset><text>Category	Characteristics	Percentage (%)	 	Signalment	Sex	FemaleMale	52.847.2	 	Reproductive status	FertileNon-fertile	6.893.2	 	Age (years)	1–55–10&gt;10	45.539.215.3	 	Breed	European shorthairSiamesePersianNorwegian Forest catOther	84.75.74.50.64.5	 	Environment	Lifestyle	IndoorIndoor/outdoorOutdoor	77.820.51.7	 	Other animals	YesNo	91.58.5	 	Co-habitant pets (n = 161)	Dog, catCatDogOther	48.430.49.311.9	 	Clinical status	Annual vaccination	YesNo	78.421.6	 	Deworming	Yes, every 3 monthsYes, every 6 monthsYes, annuallyOccasionallyNo	68.815.98.54.52.3	 	Chronic disease	NoYesDon’t know	80.112.57.4	 	Type of chronic disease (n = 22)	Kidney/liver diseaseRetroviral infectionHeart diseaseGingivostomatitisHypothyroidismOther	22.722.718.29.14.622.7	 	Medication (n = 9)	Food supplements (oral hygiene, feline idiopathic cystitis, behavior, immunomodulators)Non-steroidal anti-inflammatory drugsSteroidal anti-inflammatory drugs	66.722.211.1	 	Clinical signs or behavior changes during pandemic	NoYes	82.417.6	 	Type of clinical signs or behavior changes during pandemic (n = 31)	Behavioral changesWeight lossRespiratory clinical signsAppetite lossDigestive clinical signsConjunctivitisFeverSkin problemsOther	67.79.79.76.56.66.53.23.26.5	 	Interaction with humans	Before pandemic, type of interaction	Playing, petting, and cuddlingResting on the lapSharing the bedSharing the sofaOther	96.072.265.964.813.7	 	Before pandemic, frequency of interaction	All dayPart of the dayOccasionallyDid not interact	48.346.06.250.57	 	After household human COVID-19 diagnoses (n = 36)	As usualReduced interactionDid not interact	86.111.12.8	 	</text></passage><passage><infon key="file">vetsci-09-00363-t003.xml</infon><infon key="id">vetsci-09-00363-t003</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>45479</offset><text>Characterization of SARS-CoV-2-seropositive cats.</text></passage><passage><infon key="file">vetsci-09-00363-t003.xml</infon><infon key="id">vetsci-09-00363-t003</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Category&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Characteristics&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cat 1&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cat 2&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cat 3&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td rowspan=&quot;4&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; colspan=&quot;1&quot;&gt;Signalment&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sex&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Female&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Male&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Male&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Reproductive status&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Neutered&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Spayed&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Spayed&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Age (years)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1–5&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;lt;1&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&amp;gt;10&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Breed&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;European shorthair&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;European shorthair&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Siamese&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;2&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; colspan=&quot;1&quot;&gt;Environment&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Lifestyle&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Indoor&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Indoor&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Indoor/outdoor&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Co-habitants&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dog, cat&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dog, cat&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dog, cat, bird&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;4&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; colspan=&quot;1&quot;&gt;Clinical status&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Vaccination&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes, annually&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes, annually&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;No&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Deworming&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes, every 3 months&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes, every 3 months&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Occasionally&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Chronic disease/treatment&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;No&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;No&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Yes, FIV, basal cell carcinoma/corticosteroids&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Clinical signs or behavior changes during the pandemic &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;No&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;No&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;No&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td rowspan=&quot;2&quot; align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; colspan=&quot;1&quot;&gt;Interaction with humans/Frequency of interaction&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Before the pandemic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Playing, petting, and cuddling&lt;break/&gt;Resting on the lap&lt;break/&gt;Sharing the bed/All day&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Playing, petting, and cuddling&lt;break/&gt;Resting on the lap&lt;break/&gt;Sharing the bed/All day&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Playing, petting, and cuddling&lt;break/&gt; &lt;break/&gt;Resting on the lap/Part of the day&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;After COVID-19 diagnoses&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;As usual&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;As usual&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;-&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>45529</offset><text>Category	Characteristics	Cat 1	Cat 2	Cat 3	 	Signalment	Sex	Female	Male	Male	 	Reproductive status	Neutered	Spayed	Spayed	 	Age (years)	1–5	&lt;1	&gt;10	 	Breed	European shorthair	European shorthair	Siamese	 	Environment	Lifestyle	Indoor	Indoor	Indoor/outdoor	 	Co-habitants	Dog, cat	Dog, cat	Dog, cat, bird	 	Clinical status	Vaccination	Yes, annually	Yes, annually	No	 	Deworming	Yes, every 3 months	Yes, every 3 months	Occasionally	 	Chronic disease/treatment	No	No	Yes, FIV, basal cell carcinoma/corticosteroids	 	Clinical signs or behavior changes during the pandemic 	No	No	No	 	Interaction with humans/Frequency of interaction	Before the pandemic	Playing, petting, and cuddlingResting on the lapSharing the bed/All day	Playing, petting, and cuddlingResting on the lapSharing the bed/All day	Playing, petting, and cuddling Resting on the lap/Part of the day	 	After COVID-19 diagnoses	As usual	As usual	-	 	</text></passage></document></collection>
